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Neuronal exocytosis facilitates the propagation of information through the nervous system 
pertaining to bodily function, memory, and emotions. Using amperometry, an electrochemical 
technique that directly detects electroactive molecules, the sub-millisecond dynamics of 
exocytosis are revealed and the modulation of neurotransmitter secretion due to neurodegenerative 
diseases or pharmacological treatments can be studied. The method of detection using 
amperometry is the exchange of electrons due to a redox reaction at an electrochemically sensitive 
electrode. As electroactive molecules, such as dopamine, undergo oxidation, electrons are released 
from the molecule to the electrode and an oxidation current is generated and recorded. Despite the 
significance of traditional single-cell amperometry, it is a costly, labor-intensive, and low-
throughput, procedure. The focus of this dissertation is the development of a monolithic CMOS-
based neurochemical sensing system that can provide a high-throughput of up to 1024 single-cell 
recordings in a single experiment, significantly reducing the number of experiments required for 
studying the effects of neurodegenerative diseases or new pharmacological treatments on the 
exocytosis process. The neurochemical detection system detailed in this dissertation is based on a 
CMOS amplifier array that contains 1024 independent electrode-amplifier units, each of which 
contains a transimpedance amplifier with comparable noise performance to a high-quality 
electrophysiology amplifier that is used for traditional single-cell amperometry. Using this novel 
technology, single exocytosis events are monitored simultaneously from numerous single-cells in 
experiments to reveal the secretion characteristics from groups of cells before and after 
pharmacological treatments which target the modulation of neurotransmitters in the brain, such as 
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CHAPTER 1:  INTRODUCTION 
1.1 The Significance of Exocytosis 
Chemical transmissions at the synapses are an essential component of neurons, and it 
allows information to travel throughout the nervous system for body functions, memories, and 
emotions. In secretory cells, neurotransmitters are membrane-bound at high concentration in 
secretory vesicles. Neuronal excitation causes vesicle fusion with the plasma membrane, also 
known as exocytosis, in which the membrane-bound neurotransmitters are released in quantal 
events through a fusion pore, a nanoscopic channel that connects the vesicular lumen to the cell’s 
exterior (Fig. 1.1)*.  
 
Figure 1.1: Process of exocytosis. (a) A vesicle fuses with the cell membrane and prepares to 
release neurotransmitters. (b) The fusion pore is formed and the membrane can expand, enabling 
secretion of the vesicle’s quantal content. (c) The membrane fully expands and the 
neurotransmitters are released. 
Neurotransmitter secretion is modulated by molecular manipulations related to 
neurological diseases [1] and drug treatments [2]. For example, Parkinson’s disease can 
considerably reduce the quantity of dopamine release [3] while the drug L-Dopa can increase the 
amount of secretion [2]. By studying the secretion from individual vesicles, we gain rich 
information regarding the dynamics of membrane fusion [4], obtain insight into the mechanisms 
 
* In this chapter, we use material published in Nature Communications, 2021 [114], IEEE Transactions on Biomedical 
Circuits and Systems 2018, [24], and IEEE Sensors Journal, 2020 [115] 
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of neurological diseases at the molecular level [5], and learn both the desirable and undesirable 
side effects of drug treatments [6], [7]. The quantal release of neurotransmitters is a fast event, 
typically occurs in milliseconds or less, and the quantal size is small, containing less than attomoles 
of neurotransmitter molecules per quanta (vesicle) [5], [8]. 
1.2 Electrochemical Monitoring of Exocytosis using CFE Amperometry 
The amperometry technique is an electrochemical method which uses a microelectrode to 
measure the electrochemical current generated by the electroactive molecules, including 
dopamine, serotonin, epinephrine, and norepinephrine at an electrode’s surface [9]. Amperometry 
is widely used to monitor neurotransmitter release with high temporal resolution [4] as it can reveal 
the sub-millisecond dynamics of neurotransmitter release. Thusly, the technique can be used to 
reveal the rich details of individual quantal release including quantal size (# of molecules per 
vesicle), frequency, as well as the kinetics of vesicle fusion [10]. 
The method of detection for amperometry is through the oxidation of an electroactive 
molecule at an electrode. Oxidation is the process of electroactive molecules, such as the 
neurotransmitters dopamine, epinephrine, norepinephrine, and serotonin, releasing electrons into 
the electrode, generating picoampere currents that can be measured with high-quality low-noise 
amplifiers as illustrated in Fig. 1.2. Cyclic voltammetry is also a commonly used electrochemical 
method which is capable of measuring neurotransmitter levels, but this technique suffers from a 
lower temporal resolution compared to amperometry and is adequate for detecting the 
neurotransmitter level in a slow dynamic system. Conventionally, amperometric recordings are 
performed by placing a carbon fiber electrode (CFE) in close proximity to a single cell, such as a 
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dopaminergic neuron, chromaffin cell, or pheochromocytoma (PC-12) cell. This 
electrophysiological method is called single-cell amperometry and an example recording of a 
single quantal event is illustrated in Fig. 1.3.  
 
Figure 1.2: Illustration of dopamine detection by oxidation at an electrochemical electrode. 
Dopamine secreted from the secretory cell releases 2 electrons per molecule. The released 
electrons from numerous molecules create an oxidation current. The oxidation current is processed 
by a high-quality low-noise amplifier and outputs a readable signal. 
Amperometric recordings using a CFE have been imperative in studying the fundamental 
mechanism of vesicle fusion as well as the molecular effects of disease/treatment modulations over 
many decades. A phenomenon of incomplete exocytosis events allowing recycling of vesicles for 
rapid reuse is called ‘kiss-and-run’ and has been studied extensively as this secretion regulation 
provides insights into neuronal communications and potentially the mechanisms of neuronal 
plasticity [11]. The study of this phenomenon is enabled by amperometry as these events require 
an enhanced temporal resolution to study these millisecond scale kiss-and-run phenomena at a 
single vesicle scale [8], [12]–[16]. Using traditional amperometry techniques researchers have 
discovered that extracellular calcium concentration directly affects the frequency of kiss-and-run 
events [12], and more recently discovered a relationship between the polymerization of the actin 
protein and the fraction of secreted neurotransmitters during kiss-and-run events [16]. Another 
protein that has been studied extensively is the SNAP-25 protein, part of the SNARE protein 
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complex, at it is directly related to the intracellular membrane fusion required for neurotransmitter 
secretion from intracellular vesicles [6], [7], [17]. Using amperometry, the C-terminus in SNAP-
25 is revealed to modulate the rate at which neurotransmitters are secreted during exocytosis events 
and a lack of the C-terminus leads to prolonged secretion events [17]. Another protein that has 
been studied is alpha-synuclein as it has been implicated in the pathogenesis of Parkinson’s disease 
and has been found to reduce the frequency of exocytotic events by inhibition of vesicle priming 
for fusion with the cellular membrane [18]. Amperometry is also used to study the effects of 
various treatments that modulate exocytosis characteristics, such as the effects of morphine and 
curcuminoids. A study has revealed that the serotonin secreted from mast cells is reduced from 
mast cells due to sickle cell disease and exposure to morphine, which is used to treat pain due to 
sickle cell disease, nearly reverses the modulation of serotonin release in the mast cells due to the 
disease [19]. Another study has examined the effects of curcuminoids, which have been thought 
to have potential therapeutic applications for neurodegenerative diseases [20]. This study has 
revealed the effects of curcumin and bisdemethoxycurcumin, which exist in turmeric spice, and 
have found that bisdemethoxycurcumin reduces the quantal size of the exocytotic events while 
curcumin accelerates the exocytotic process [21]. In addition to treatments for neurodegenerative 
diseases, amperometry is used to study/monitor biomarkers that can reveal signs of a neurological 
disease. Amperometry has enabled the study of the concentration of nitric oxide, which is linked 
to neuronal cell death, in a rat’s brain by providing the high sensitivity and temporal response 
required to monitor the highly reactive molecule in its own physiological environment [22]. To 




Figure 1.3: Illustration of an amperometric recording of a single secretion event using a CFE. (a) 
No signal is recorded before the quantal content of the vesicle is released. (b) A small foot signal 
is detected as a small concentration of quantal content is released through the small fusion pore. 
(c) The membrane fully expands and the signal intensity is directly related to the concentration of 
quantal content that is oxidized at the electrode. (d) Neurotransmitters diffuse out of the vesicle 
until the minimal signal is recorded as the quantal content is oxidized and depletes. 
for neurological diseases, surface-modified electrodes are being developed to enable amperometry 
monitoring of biomolecules that are not inherently electroactive [23].  
1.3 Transimpedance Amplification for Picoampere Level Oxidation Currents 
The current generated from the oxidized quantal content during exocytosis is on the scale 
of picoamps. In order to convert this significantly small current into a readable voltage, 
transimpedance amplification is necessary. A basic transimpedance amplifier consists of an 
operational amplifier with a feedback resistor as shown in Fig. 1.4a. The current that is generated 
by the oxidized molecules at the electrode flows through the feedback resistor, thus resulting in an 
output voltage expressed as: 
 Vout = Ioxidation𝑅 (1.1) 
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As seen in Eq. 1.1, the output voltage is directly related to the oxidation current (Fig. 1.4b-c) 
flowing through the amplifier and is scaled by the value of the resistor used. For example, using a 
GΩ resistor the transimpedance amplifier can convert picoamp levels of current (10−12) to 
millivolts (10−3).  
 
Figure 1.4: Transimpedance amplifier. (a) This transimpedance amplifier topology consists of an 
operational amplifier with a feedback resistor. (b) An example input current signal. (c) The output 
voltage of this transimpedance amplifier converts the pA level current input into a V level output. 
Another topology for transimpedance amplification is a capacitor-based amplifier as shown 
in Fig. 1.5a. This amplifier specifically integrates the electrons released from the electroactive 
molecules onto the capacitor node labeled Vout. This results in a change in the voltage from the 
initial state of VDD at the Vout node as the electrons accumulate (Fig. 1.5b), thus reducing the 
potential of the output voltage as more electrons are integrated onto the capacitor. At a periodic 
interval (T), the total voltage drop is readout from the amplifier and Cint is reset during readout by 
closing the switch SW (Fig. 1.5a) to begin the next integration cycle (Fig. 1.5b). The output voltage 
of this transimpedance amplifier is expressed as:  
 








   
7 
 
Figure 1.5: Capacitive Transimpedance Amplifier (a) The electrons from the oxidation reactions 
at the electrode are integrated onto Cint. (b) As the electrons accumulate at the Vout node, the 
output voltage decreases from the initial VDD potential. The change in voltage is periodically 
readout and the integration capacitor is reset to begin the next integration cycle.  
As an example of this topology’s output, if there is a constant 1 picoamp current that is integrated 
over 100 μs (10 kHz sampling rate) onto an integration capacitor of 116 fF [24], the resulting 
change in output voltage is ~0.86 mV.  
A 116 fF capacitance is integrated into each amplifier of the neurochemical array [24] 
presented in this dissertation and occupies a small ~10μm × 10μm. Based on Eq 1.2, we can see 
that the amplification of the oxidation current can increase by either increasing the integration 
period or reducing the integration capacitor. However, by increasing the integration period the 
sampling rate is reduced, which is undesirable in capturing the fast exocytotic events. Therefore, 
reduction of the integration capacitor, which also reduces the space required for each amplifier, is 
the favorable technique to increase the transimpedance gain.  
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Either the resistor- or capacitor-based TIA topologies are acceptable for traditional single-
cell amperometry as the space required to operate a few of these amplifiers does not present a 
significant constraint. However, research is moving towards high-throughput techniques to enable 
accelerated single-cell studies, such as neurodegenerative disorders and new emerging 
pharmacological treatments, as discussed in the next section. As the number of amplifiers increases 
from 10s, to 100s, and then 1000s, the area required for the amplifiers becomes prohibitive. A 
single GΩ resistor can occupy considerable space in the layout of a CMOS design, and thus the 
resistor-based transimpedance amplifier shown inf Fig. 1.4 becomes impractical when making 
amplifier arrays with 100s or 1000s of amplifiers. Alternatively, the small capacitive TIA shown 
in Fig. 1.5 can be used to enable large-scale transimpedance amplification arrays for 
neurochemical monitoring of fast exocytosis events from neurons. 
1.4 Limitation of CFE-based Single-cell Amperometry  
Despite the significance of the studies conducted and the discoveries made using 
amperometry, traditional amperometric measurements conducted at the single-cell level are 
traditionally a low-throughput method where each cell is measured individually with a 
microelectrode under microscopic observation. This makes the technology time-consuming to 
acquire sufficient data to derive statistically significant conclusions. Additionally, it is important 
that amperometry is performed at the single-cell level to account for heterogeneity in the 
characteristics of quantal release among the cell population [10], [25]. Therefore, to compare the 
kinetics of quantal release and the size of vesicle secretion with statistical significance, typically 
more than 30 independent cell measurements are collected for both the experimental and control 
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groups to develop meaningful conclusions. These low-throughput studies and can take from weeks 
to several months [26] to research the effects of neurological diseases or pharmacological 
treatments on exocytosis dynamics. Thusly, the prohibitive features of single-cell amperometry 
have limited the wide application of this technology to survey (or screen) the molecular effects of 
pharmacological modulations and neurodegenerative pathologies associated with the synaptic 
neurotransmitter secretion process.  
To overcome the low-throughput nature of traditional single-cell techniques, large-scale 
MEAs offer high-throughput capability for single-cell studies. MEAs have been previously used 
for single-cell detection of quantal exocytosis from chromaffin cells [27], capturing the single-cell 
level exocytosis heterogeneity of PC-12 cells [28], real-time monitoring of the quantal release of 
dopamine from PC-12 cells during the culture or propagation process [29], and capturing the 
reuptake inhibition effects of nomifensine on PC-12 cells [30]. Additionally, MEAs have been 
useful in enhancing the spatial resolution of electrochemical recordings. Such as mapping the level 
of H2O2 in relation to neurological diseases in a brain slice [31], electrochemical imaging of redox 
molecules diffusing across an MEA [32], and imaging of metabolites in biofilms [33]. The high-
throughput simultaneous measurements from a large number of cells enabled by MEAs results in 
a tremendous benefit in enabling rapid studies of neurodegenerative disorders and the effects of 
therapies as well as new drug discoveries that target the modulation of neurotransmitters.  
However, the electrodes throughout an MEA must be connected to external amplifiers for 
signal amplification and processing. The use of external amplifiers becomes prohibitively 
expensive as the number of simultaneous recordings grows (for single-cell electrophysiology 
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~$15,000 per amplifier), but more importantly, it sets a limit on the total number of electrodes in 
an array because the external wiring becomes impractical.  
1.5 CMOS-based Microelectrode Array 
To resolve the challenges with increasing the density of parallel recordings using an MEA, 
we can integrate an array of amplifiers and on-chip electrodes in a CMOS chip. This method 
drastically lowers the cost per amplifier and removes the need for external wiring because the on-
chip electrode and on-chip amplifier establish a connection within the chip. Therefore, the CMOS-
based MEA opens the opportunity to increase the electrode count of an MEA to above 1000s.  
Several CMOS-based biosensors have been proposed using this concept of MEA 
integration [34]–[39] to perform various types of electrophysiology. Developed CMOS-based 
biosensors have demonstrated their parallel recording capabilities through the mapping of the 
concentration of ferricyanide across a 16 × 16 electrode array [40], the diffusion of H2O2 in a 32 
× 32 electrode array [32], and the flow injection of several analytes across a 128 × 128 electrode 
array [41]. For the purpose of measuring action potentials from a neuron with a high spatiotemporal 
resolution, a multifunctional CMOS chip with an array of 59,760 on-chip electrodes can provide 
a high channel count of up to 2048 electrodes for simultaneous recording [36], [42]. This 
multifunctional CMOS chip featured 28 amplifiers for neurotransmitter detection using cyclic 
voltammetry with a noise level of 100s of pARMS. Using an array of 11,011 electrodes, action 
potentials from axons in a neuronal network were measured with high spatiotemporal resolution 
[37], [43]. Impedance spectroscopy with a high spatial resolution and low-noise was performed 
with an array of 59,760 electrodes integrated onto a multifunctional CMOS chip [44]. To study 
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bursting events from neurons in a neuronal network, a device providing high spatial resolution 
with an array of 4096 electrodes was proposed [45]. Another proposed system contains 1024 pixels 
to provide a low-noise multifunctional CMOS device with enhanced spatiotemporal resolution for 
extracellular potential measurement, optical cell detection, current stimulation, and cellular 
impedance measuring [39]. Furthermore, these CMOS-based bioelectronic systems have been 
developed and used for high-throughput recordings of neurotransmitter secretion from bovine 
chromaffin cells with a 10 × 10 electrode array [26], [34].  
1.6 Outline of Dissertation Organization and Contents 
This dissertation outlines the development of a CMOS-based neurochemical MEA for 
high-throughput monitoring of neurotransmitter secretion at the single-cell level. The 
methodology supporting the development of this novel technology and the studies performed using 
this new instrumentation are summarized in the following chapters. A small 30 μm × 30 μm 
transimpedance amplifier, which is based on current integration onto a capacitor, was developed 
to detect the small pA currents from neurotransmitter secretion. Additionally, high-density 
integration of this small 30 μm × 30 μm amplifier is achieved by a half-shared amplifier design, 
wherein the half-shared structure improves the scalability of the amplifiers by sharing the non-
inverting side of the operational amplifier with many inverting halves. The design and performance 
of this transimpedance amplifier array, enabling high-density neurochemical recordings, are 
discussed in chapter 2. In chapter 3, parallel 1024 cyclic voltammetry is performed using the 
integrated neurochemical electrode array. These cyclic voltammetry recordings are used to 
examine the quality of electrochemical electrodes by measuring the double-layer capacitance that 
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forms at the electrode-electrolyte interface as this capacitance is directly related to the effective 
area of the electrodes. This measured capacitance reveals the contamination on the electrodes and 
determines how much plasma treatment is needed to descum the surface of the electrode. Fast 
electrochemical imaging of the diffusion of dopamine and hydrogen peroxide is recorded at 40,000 
frames per second across the developed neurochemical detector array. To support the high level 
of data generated by the neurochemical detection array for this electrochemical imaging, a custom 
FPGA-based data acquisition system is designed to interface with the high-density neurochemical 
detection array and is discussed in chapter 4. In chapter 5, the secretion of neurotransmitters from 
human neuroblastoma cells (SH-SY5Y) are recorded and characterized with single-cell resolution. 
Secretions from 76 cells are simultaneously recorded by loading the developed device with SH-
SY5Y cells. The data presented in chapter 5 shows the device’s capability of recording vesicle 
secretion at a single-cell level, with 1024 parallel channels, to provide high-throughput detailed 
information on the dynamics of dopamine release at a single-vesicle resolution. In chapter 6, the 
developed 1024 neurochemical microelectrode array is applied to study the modulation of 
neurotransmitter secretion after treating cells with drugs used for treating Parkinson’s disease and 
depression. The modulation of neurotransmitter secretion dynamics due to L-Dopa (Parkinson’s 
disease treatment), selegiline (Parkinson’s disease treatment), or desvenlafaxine (depression 
treatment) are investigated and presented in this dissertation. In chapter 7, a novel biohybrid 
synapse that produces quantal neurotransmitter secretion to relay information to an artificial 
postsynaptic receptor is developed. This neurochemical biohybrid synapse paves the way for a 
new generation of brain-inspired computing by enabling single biological cell to single artificial 
neuron connectivity. 
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The presented novel CMOS-based neurotransmitter detection system can capture a large 
pool of quantal events in the span of minutes, providing rapid results compared to the conventional 
amperometry technique that can take from weeks to months to amass a comparable dataset [26]. 
Using this novel technology, we can significantly accelerate the study of neurodegenerative 
disorders, such as Parkinson’s disease and Alzheimer’s disease, as well as new pharmacological 
treatments that affect neurotransmitters in the brain at the single-cell level, such as drugs for 
depression or Parkinson’s disease.  
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CHAPTER 2:  HALF-SHARED TRANSIMPEDANCE AMPLIFIER FOR 
PICOAMPERE BIOSENSOR MEASUREMENTS 
2.1 Chapter Notes 
In this chapter, the design of a small 30 μm × 30 μm transimpedance amplifier, which is 
based on current integration onto a capacitor, is developed to detect the small pA currents from 
neurotransmitter secretion. High-density integration of this amplifier is achieved by a half-shared 
amplifier design. The half-shared amplifier improves the scalability of the amplifiers by sharing 
the non-inverting side of the operational amplifier with many inverting halves. The performance 
of the transimpedance amplifiers using the half-shared amplifier structure is characterized to 
demonstrate the isolation between the amplifiers in the shared structure, enabling high-density 
integration of amplifiers with independent neurotransmitter detection capability. The amplifier 
array discussed in this chapter is the basis for the single-cell neurochemical sensing device 
presented in this dissertation. The work described in this chapter was completed with Geoffrey 
Mulberry and Brian N. Kim *.  
2.2 Introduction 
A transimpedance amplifier (TIA) is used in bioelectronic systems to measure currents in 
biological applications, including in vivo and ex vivo dopamine measurements [46]–[48], single-
cell amperometry [24], [42], [49]–[51], photoplethysmography (PPG) [52]–[54], pulse oximetry 
[55], and nanopore recordings [35], [56]. They traditionally consist of a circuit to transform the 
current into the electrode into a voltage measurement. To implement a TIA, most low-noise 
 
* In this chapter, we use material published in IEEE Transactions on Biomedical Circuits and Systems, 2019 [61]. 
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measurements use an operational amplifier (OPA) to hold an electrode or a photodiode at a 
reference voltage while converting the current at the electrode or photodiode into voltage, thus 
forming a transimpedance amplifier. As such, TIAs on integrated CMOS devices usually contain 
OPAs within them. For high-throughput (large-scale) measurements from an array of detectors, a 
larger number of amplifiers is required. Thus, it is crucial to minimize the size requirements of 
each TIA if a larger scale recording is desired. One approach for minimization of TIAs is the half-
shared structure of the OPA, which is explored and analyzed in this chapter. The approach is 
powerful, as it enables the doubling of amplifiers on a single chip, increasing throughput for 
demanding applications. However, few in the field have been using the technique for their designs, 
possibly due to a lack of awareness and analysis of the concept which will be addressed by this 
chapter. 
The half-shared design has been successfully adapted in previous studies to yield large-
scale recordings, ranging from tens to thousands of amplifiers [24], [34], [49], [51], [57], [58]. The 
design principle of a half-shared OPA is to allow for the non-inverting half to be shared between 
multiple OPAs, reducing the required die area for multiple OPAs by nearly a factor of two. In an 
effort to have high bandwidth and a wide dynamic range, a folded-cascode architecture was used 
for the early half-shared amplifiers [49]. This folded-cascode architecture achieves a wide dynamic 
range and bandwidth at the cost of high power (nearly double) and area consumption. However, if 
used for most electrophysiology or photodiode applications, the required bandwidth is small (< 20 
kHz). Additionally, many CMOS detector arrays for biomedical applications operate below 20 
kHz, usually in the 10 kHz region [57], [59]. This low bandwidth can be easily obtained with a 
traditional five transistor (5T) OPA, further eliminating significant benefits to the folded-cascode 
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architecture. Thus, the 5T OPA design is adapted in this work to minimize the power and area 
consumption.  
The half-shared structure has been analyzed in the past for a limited amount of scalability, 
usually, two OPAs sharing one non-inverting half [49], [60]. In this chapter, we will expand the 
analysis for an unspecified number of sharing branches to evaluate the effect and implications for 
larger-scale recordings (Section 2.3). Using the half-shared design, an integration-based TIA is 
designed and tested. The noise analysis of non-stationary circuits, such as an integration amplifier, 
is a challenging task. This is because most noise simulations assume a steady-state in the time-
domain for the frequency-domain analysis. In order to evaluate the noise characteristics of non-
stationary TIAs, we produced a simple approach to convert the integration amplifier to a stationary 
circuit for the noise analysis and applied post-signal-processing to simulate the non-stationary 
effect (Section 2.4). To study the 5T half-shared OPA structure, a CMOS chip [51] was designed 
and fabricated using a 0.35 μm 4M2P process. Since the techniques described in this chapter are 
valid for all process nodes, a 0.35 μm process was chosen as a cost-effective means to fabricate 
this proof-of-concept work. These techniques can be implemented on any modern analog CMOS 
process to further reduce die area required for large arrays. In biological applications, the voltage 
required to monitor or stimulate the electrophysiological processes is often larger than few volts 
and the larger dynamic range of large process nodes, such as 0.18 and 0.35 μm, is useful. Section 
2.3 discusses the design of the TIAs, OPAs, and array in detail. In short, the CMOS chip consists 
of a total of 1024 array elements arranged into a 32 × 32 grid. The TIAs within each array element 
are based on OPAs utilizing the half-shared design and have additional circuitry allowing for 
reconfiguration for testing and different modes of operation. Although each TIA relies on the half-
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shared OPA architecture, they are effectively independent from the others, allowing 1024 parallel 
measurements. The fabricated circuit is used to characterize the performance of the half-shared 
design, including gain, linearity, noise, mismatch, bandwidth, and crosstalk (Section 2.5).  
2.3 Transimpedance Amplifier Array Design 
The half-shared OPA design is described within this section along with how they are used 
within the TIAs and array elements and the overall structure of the array. The TIAs used rely on a 
rather simple design of OPA. Although rudimentary, the 5T OPA’s lend themselves well to half-
sharing, use low power, require little die area, and their performance within the presented TIA 
design is sufficient as will be demonstrated in sections 2.4 and 2.5. 
2.3.1 Half-shared Amplifier Design 
The enabling feature of this array’s high density is the half-shared architecture used for the 
OPAs within the TIAs. The basis of the half-shared design exploits redundancies that occur when 
traditional 5T OPAs in the negative feedback configuration are used in parallel, and their non-
inverting inputs share the same voltage. A half-shared OPA schematic is presented in Fig. 2.1. 
Here, M0 and M1 form a differential pair, where Mbias provides a bias current, and ML0 and ML1 
form a current mirror load for the differential pair. The non-inverting and inverting inputs are the 
gates of M0 and M1, respectively. The output is taken at the drains of ML1 and M1.  
Usually, if a second 5T OPA is added, five additional transistors would be required. 
However, if the bias current and the non-inverting input voltage are the same for the two OPAs, 
only two additional transistors are required. This is due to the redundancy within the non-inverting 
half. Thus ML0 and M0 can be shared between the two OPAs. In this example, ML2 and M2 are all 
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that is required to add a second OPA. For the second OPA, M2 and M0 form the differential pair 
where M2’s gate is the second inverting input. Conceptually, this method can be extended to any 
amount of additional OPAs.  
2.3.2 Analysis of Half-shared Structure 
The circuit in Fig. 2.2 shows multiple inverting half amplifiers sharing a single non-
inverting half. To examine the tradeoff of multiple inverting halves sharing a single non-inverting  
 
Figure 2.1: A half-shared design with k-counts of inverting amplifier shared a single non-inverting 
half. Transistors M0 and ML0 form the non-inverting half and M1-Mk, ML1-ML,k form inverting 
halves of additional OPAs. All NMOS and PMOS bulk connections are to ground and VDD 
respectively. 2019 © IEEE 
half, the small-signal gain of each branch is analyzed. The purpose of this analysis is to evaluate 
the performance of the half-shared structures before it is placed and used as a part of our TIA. The 
current in the non-inverting half can be expressed: 
 𝑖𝑑0 = 𝑔𝑚0(𝑣𝑖𝑛0 − 𝑣𝑐𝑜𝑚) (2.1) 
   
where gm0 is the transconductance of M0. 
Assuming the transconductances of M0, M1, M2, and Mk are equal, currents in inverting 
halves can be generally expressed: 
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 𝑖𝑑,𝑘 = 𝑔𝑚(𝑣𝑖𝑛,𝑘 − 𝑣𝑐𝑜𝑚) (2.2) 
   
where k is the kth inverting half amplifier sharing the common non-inverting half. Because 
Mbias supplies constant current for biasing, it is removed from the small-signal circuit, thus 
 𝑖𝑑0 + 𝑖𝑑1 + 𝑖𝑑2 + ⋯ + 𝑖𝑑,𝑘 = ∑ 𝑖𝑑,𝑛
𝑘
𝑛=0 = 0. (2.3) 
   









   
Load transistors, ML0, ML1, ML2, and ML,k, form a current mirror and thus currents through 
these transistors are equal.  
 
Figure 2.2: Block diagram of the CMOS design containing 1024 half-shared amplifier array 
elements. Each block consists of a group of four amplifiers using the half-shared architecture to 
save silicon area while increasing the number of on-chip amplifiers. Each OPA is represented as 
cut in half, with the right half being the inverting side located within a corresponding TIA, and the 
left half being the non-inverting half common to each block of four amplifiers. The array is eight 
groups of four amplifiers wide and 32 rows tall to create a total of 1024 amplifiers. Each inverting 
inputs are labeled with its row- and column- coordinate position as their indices. 2019 © IEEE 
 𝑖𝐿0 = 𝑖𝐿1 = 𝑖𝐿2 = 𝑖𝐿,𝑘 = 𝑖𝑑0. (2.5) 
   
The current entering the node Vout1 is 
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 𝑖𝑜𝑢𝑡,1 = 𝑖𝐿0 − 𝑖𝑑1 = 𝑖𝑑0 − 𝑖𝑑1, (2.6) 
   
and this current used to generalize other halves’ output current, 
 𝑖𝑜𝑢𝑡,𝑘 = 𝑖𝑑0 − 𝑖𝑑,𝑘. (2.7) 
   
Because vout,k is loaded by the output resistance of ML,k and Mk, rL,k and rk, vout,k can be 
expressed as: 
 𝑣𝑜𝑢𝑡,𝑘 = (𝑟𝐿,𝑘//𝑟𝑘) ∙ 𝑖𝑜𝑢𝑡,𝑘. (2.8) 
   
Using Eqs. (2.2), (2.3), (2.4), and (2.7), 
 𝑣𝑜𝑢𝑡,𝑘 = −(𝑟𝐿,𝑘//𝑟𝑘) ∙ (∑ 𝑖𝑑,𝑛
𝑘
𝑛=1 + 𝑖𝑑,𝑘),  
 = −𝑔𝑚 ∙ (𝑟𝐿,𝑘//𝑟𝑘) ∙ [(∑ 𝑣𝑖𝑛,𝑛
𝑘
𝑛=1 ) + 𝑣𝑖𝑛,𝑘 − (𝑘 + 1) ∙ 𝑣𝑐𝑜𝑚]   
 = −𝑔𝑚 ∙ (𝑟𝐿,𝑘//𝑟𝑘) ∙ [(∑ 𝑣𝑖𝑛,𝑛
𝑘
𝑛=1 ) + 𝑣𝑖𝑛,𝑘 − (∑ 𝑣𝑖𝑛,𝑛
𝑘
𝑛=0 )]   
 = −𝑔𝑚 ∙ (𝑟𝐿,𝑘//𝑟𝑘) ∙ (𝑣𝑖𝑛,𝑘 − 𝑣𝑖𝑛0). (2.9) 
   
In Eq. 2.9, we can see that the output (vout,k) of a particular inverting half is only dependent 
on vin,k and vin0, not related to other inverting halves’ inputs. Thus, multiple inverting halves can 
operate independently without suffering crosstalk. This analysis also reveals that there is no 
obvious limit on how many inverting halves can be attached to share a single non-inverting half.  
In the half-shared design, the bias current of each amplifier is provided from Mbias. 
Therefore, if the number of inverting half amplifiers increases to share the single non-inverting 
half, the current level through Mbias should linearly increase to supply consistent levels of bias to 
individual amplifiers. This requires Vbn to be elevated. To operate Mbias in saturation, Vcom needs 
to be increased with Vbn, which will limit Vbn – Vcom to be less than the threshold voltage. Thus, 
one apparent tradeoff of increasing the number of sharing amplifiers is the reduced dynamic range 
of Vin,k and Vout,k. This effect could be reduced by increasing the width of Mbias, however, since 
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the objective of half-sharing is to reduce die area, Mbias must be sized as a compromise between 
size and number of shared branches.  
2.3.3 Large Array Design using Half-shared Structure 
The large array of densely packed TIAs consisting of 1024 amplifiers on a single CMOS 
chip uses the half-shared structure to its advantage. In this case, we chose to have four inverting 
amplifiers to share one non-inverting half considering the required dynamic range for biomedical 
applications. For the large array, an important design requirement is that, for this architecture to 
work properly, transistors M0, M1, M2, M3, and M4 must all be matched sizes, as well as load 
transistors ML0, ML1, ML2, ML3, and ML4. If the sizes are not matched, then the individual half 
currents will be unequal and Eqs. (2.5), (2.6), (2.7), and ultimately (2.9) will be invalid. The 
consequence of poor matching is that the inverting halves will no longer be independent. The 
arrangement of the TIAs for the large array is shown in Fig. 2.2. A 32 × 32 grid is used to arrange 
the 1024 amplifiers as densely as possible. Along any given row, eight half-shared blocks are used 
where every group of four amplifiers along the row are part of a half-shared block. Using this 
arrangement of eight half-shared blocks allows 32 TIAs to fit in the same die area that could fit 
only 17 TIAs using traditional 5T OPAs. This increase in packing density provides an effective 
method for increasing the throughput of parallel measurements. The Vpos terminals of the eight 
half-shared blocks in each row are connected together and are additionally connected to all 32 
rows. This enables a global Vpos for setting all 1024 electrode potentials when performing current 
measurements in electrolytic solutions. Such measurements are the basis for single-cell 
electrophysiology and amperometry experiments. Each column has its own analog output enabling 
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entire rows of 32 TIAs to be read out simultaneously row after row. While one row is being read 
out, the other 31 in the same column are performing integration of their electrode currents, enabling  
 
Figure 2.3: Schematic of an individual transimpedance amplifier element. The circuit is a 
reconfigurable and programmable using the embedded SRAM. The design includes the inverting 
half of an OPA and shares the non-inverting half which is separated so it can be shared with three 
other amplifiers. Similar to Fig. 2.1 and Fig. 2.2, the shared nodes Vout0 and Vcom are represented 
as dashed lines, showing the connections of the half-shared OPA blocks. Vout,k is the output of the 
non-inverting OPA half for this TIA element. 2019 © IEEE 
a true 1024 simultaneous measurements without deadtime. The detail of the staggered time-
division multiplexing is previously described by the authors [24], [34]. 
2.3.4 Programmable TIA 
Fig. 2.3 shows the schematic for one of the 1024 TIAs using the half-shared amplifier. 
Each TIA contains 11 MOSFETs, a half-shared OPA, an SRAM, and two capacitors. The TIA 
design is based on a regulated cascode amplifier (RCA). The current at the electrode is integrated 
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at the drain node of M9 which is then measured as a voltage by M10 and M11, periodically (tint). 
Normally, an integrating capacitor (Cint) should be placed at the drain node of M9 which sets the 




 (𝑉/𝐼). (2.10) 
   
To maximize the transimpedance gain, the parasitic capacitance (<10 fF) which exists at 
the drain node of M9 is used. The integrating TIA design achieves similar or better noise 
performance compared to a resistive TIA, but with a high area efficiency due to the lack of the 
resistor. M1 forms half of a current mirror used to set a calibration current through the TIA via Ical, 
mainly for testing the transimpedance gain but also to allow the measurement of negative currents. 
Because we intended to operate the OPA with extremely low power, the phase margin of the RCA 
can be low with poles from the OPA and M9 source, closely overlapping. Optional phase 
compensation can be enabled when PC (phase compensation switch enable) is high by turning on 
switches, M2 and M3, and inserting CPC into the feedback loop, thus increasing the phase margin. 
The integration capacitance is reset by switch M4 every integration period (tint). The TIA has two 
programmable gain settings enabled by CLoG. CLoG can be added to the parasitic integration 
capacitance by turning on switch M8 to decrease the gain in low-gain mode by setting LoG low. 
Thus, in the low-gain mode, the integration capacitance is a summation of CLoG and the parasitic 
capacitance. The TIA can be connected to an external electrode pad, ExConE, by turning on switch 
M7 when the SRAM is set high. An additional function of the SRAM is to use the OPA to be in 
the unity-gain mode when SepHold̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ and the SRAM are both high. When both M5 and M6 are on, 
the inverting input of the OPA and the output are shorted, enabling unity-gain. Every TIA has a 
dedicated SRAM within the 900 μm2 for the fully-addressable programmable array. Switch M11 
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allows for connection to the column’s output buffer, where M10 is one of the output buffer 
transistors when Row Select is high. The minimum dimension is used for all switch transistors. 
For best matching characteristics, analog transistors M9 and M10 are square. 
For this array design, each array element is set to be 30 μm × 30 μm. This is to integrate 
the entire 1024 amplifier array in less than a 1-mm2 area. Transistors for the OPAs, Mbias, Mk, and 
ML,k, are sized at 10 μm × 10 μm to minimize mismatch. Without the half-shared architecture, the 
gates of the transistors alone for a single OPA require 500 μm2 or 55.8% of the 900 μm2 available 
for each array element. This would leave insufficient area for the remaining circuitry shown in Fig. 
2.3. However, with the half-shared structure, only 2 OPA transistors must fit into each array 
element, requiring 200 μm2 or 22.2% of the array element area, allowing for the addition of the 
extra circuitry. 
2.4 Noise Analysis of Non-stationary Circuit 
The integration TIA has an integrating node where voltage can swing up to 2 volts within 
the integration period, which then resets after each integration cycle. Thus, this circuit is non-
stationary in the time-domain and the simulation in the frequency domain is difficult to implement. 
Thus, in this section, we are exploring a conversion method to estimate the noise performance for 
a non-stationary circuit using a typical simulation tool.  
2.4.1 Non-stationary Circuit 
The integrating circuit is only functional if the integration capacitor is periodically reset. 
Without the periodical reset, the charge in the integration node discharges completely which 
disables the TIA. Thus, the circuit in Fig. 2.3 cannot be used for a typical AC/noise analysis. This 
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non-stationary circuit can be converted to a stationary circuit by replacing the integration capacitor 
with a resistor. The value of the resistor should be: 
 





   
where the resistance is identical to the transimpedance gain set by the integration period 
and integration capacitance. The resistor-based circuit is then used for the noise analysis with the 
noise model provided by the semiconductor manufacturer. The noise measured at the integration 
node consists of various noise sources from the OPA, cascode transistor (M9), and the resistor. 
This analysis does offer some insight into the characteristics of the TIA’s noise but fails to capture 
the effect of the current integration. The current integration for the set duration in a time domain 
creates a convolution of a rectangular pulse (Fig. 2.4a).  
 𝑖𝑇𝐼𝐴 (𝑡) = 𝑖𝑖𝑛𝑡(𝑡) ∗ 𝑟𝑒𝑐𝑡(𝑡)            (2.12) 
   
where the rect(t) is the rectangular function (1 for arguments within a window of period 
tint, and 0 for all arguments outside of the window) and iint is the current measured at the integration 
node. This expression can be transformed to the following equation: 
 𝐼𝑇𝐼𝐴 (𝑓) = 𝐼𝑖𝑛𝑡(𝑓)𝑌(𝑓)              (2.13) 
   
where Y(f) is the Fourier transform of the rectangular function. The unitary Fourier 
transform of rect(t) is 
 𝑌(𝑓) = ∫ 𝑟𝑒𝑐𝑡(𝑡) ∙ 𝑒−𝑖2𝜋𝑓𝑡𝑑𝑡 
∞
−∞
.              (2.14) 
   




= 𝑠𝑖𝑛𝑐(𝑓 ∙ 𝜋 ∙ 𝑡𝑖𝑛𝑡). (2.15) 
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Figure 2.4: Characterization of noise using simulation and chip measurement. (a) The current 
integration creates windows for each integration period and reports the current level at the end of 
each integration cycle. The window in time-domain generates a sinc() function in the frequency 
domain which can be used to estimate the noise performance in the non-stationary circuit. (b) 
Noise analysis from the simulation is compared with the chip measurements for various input 
current levels, 50 pA, 75 pA, and 100pA. 2019 © IEEE 
The multiplier, π·tint, is to adjust the sinc() filter for the specific rectangular function which 
has the tint window. Any input passing Y(f) with 1/tint interval frequencies should have zero output. 
To generate the equivalent noise analysis from the stationary circuit to the non-stationary circuit, 
a post-signal-processing can be applied by multiplying the noise measurement from the simulation 
with Eq. 2.15. 
 𝐼𝑝𝑜𝑠𝑡(𝑓) = 𝐼𝑟𝑒𝑠(𝑓)𝑌(𝑓). (2.16) 
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Therefore, Ipost(f) closely estimates ITIA(f) in Eq. 2.13. One difference is the thermal noise 
added by the resistor in the simulation. This effect can be extracted from Eq. 2.16 if relevant. Since 
the gain we are simulating is 7.00 mV/pA, the resistor we use is 7 GΩ. The thermal noise of the 7 
GΩ resistor is only ~2×10-6 pA2/Hz and is significantly smaller than the typical noise in the TIA, 
so we have ignored it in the analysis.  
The simulated noise is shown in Fig. 2.4b with the measured noise from the CMOS chip at 
various input current levels, 50pA, 75pA, and 100 pA. All noise measurements show 1/f noise at 
low frequencies. At high frequency, the effect of post-signal-processing of adding sinc() response 
is observed as expected. For all three input current levels, the noise levels between the 
measurement and the simulation are within a factor of 5, which reveals the discrepancy of the noise 
characteristic in deep weak inversion. The input current below nano-ampere is considered deep 
weak inversion and the noise model provided by the manufacturer are generally optimized for 
strong inversion transistors. Therefore, for any amplifiers operating with pico-ampere current 
levels, the noise characteristic can be better evaluated by measurements, rather than modeling and 
simulation. Nonetheless, the simulation method presented here does provide a viable method to 
estimate the noise level and the frequency characteristics within a factor of 5 before the CMOS 
fabrication.  
2.5 Characterization and Measurement 
To demonstrate the effectiveness of the half-shared architecture, the fabricated CMOS 
array was used for several experiments using the test setup shown in Fig. 2.5. This section contains 
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measurements of a representative column’s output, transimpedance linearity, amplifier mismatch 
of the 1024 TIAs, and frequency response. 
2.5.1 Transimpedance Measurement 
The half-shared TIA’s transimpedance conversion performance is studied by first 
configuring the amplifiers to low gain mode, applying a known DC Ical input (from 0 to 1000 pA), 
and measuring the output waveforms. The array is equipped with multiplexers as previously 
described in [34], [51] to reduce the number of outputs. 32 TIAs in a column share a 32-to-1 time-
division multiplexer. The waveforms resulting from this multiplexed transimpedance  
 
Figure 2.5: Overview of the measurement system. The CMOS chip is bonded to a PCB which is 
inserted into a socket on the socket board. The socket board allows for connections to the National 
Instruments DAQ unit and to the biasing board. The biasing board converts battery or power supply 
voltage into VDD, Vreset, Vpos, and Ical. Ical is easily adjustable via the 10-turn potentiometer. 2019 
© IEEE 
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measurement are shown in Fig. 2.6. The separate traces represent the voltage output versus time 
of a single column’s output at a specific Ical level. The square shape of the pulses resulting from 
the correlated double sampling (CDS) output stage are clearly shown. CDS allows for the removal 
of the offset produced by Vreset by sampling at both the reset and output values and performing a 
subtraction. The left plot shows the output from a single column measurement (the pulses are the 
32 TIAs in that column). The inset plot shows only four rows of the same output, which more 
clearly shows the linearity of the output voltages for the first four TIAs in the column. The different 
heights of the pulses indicates a difference in the gain of each of the amplifiers. The difference in 
gain between the amplifiers is likely caused by process variations such as the dimensions of the 
transistors, causing mismatch of the OPA inputs, and the dimensions of the integrating capacitors. 
Parasitic capacitance variation across the array could also affect the gain, so care must be taken in 
the layout to ensure that the array elements are identical. It is important to note, however, that these 
variations may vary between array elements but should be consistent within any given array 
element. As a result, the variations can be calibrated out by applying known signals via Ical and 
recording the gain of each amplifier before taking measurements.  
2.5.2 Transimpedance Gain Linearity 
The TIA’s linearity performance is evaluated by using the data from the transimpedance 
recording shown in Fig. 2.6 and creating the voltage versus current plot shown in Fig. 7a. The 
results from all 32 TIAs’ outputs are used to create a least-squares linear fit of Vout against Ical. 
Based on the fit, the transimpedance gain of the low-gain mode is 0.86 mV/pA. The resulting fit 
has an R2 value of 0.999, indicating a high-quality linear performance of the TIAs. We have 
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performed the same measurement for the high-gain mode. The transimpedance gain of the high-
gain mode is 7.00 mV/pA, and the R2 value is 0.988. The relatively low coefficient of 
determination in the linear fitting for the high-gain mode is apparent in Fig. 2.7a which has a small 
curvature around 50 – 60 pA. This is likely due to the nature of parasitic capacitance which is 
mainly composed of junction and gate capacitors at the integration node. To study the linearity of 
the entire array, Ical is also measured from all 1024 amplifiers at 700 pA and 200 pA and the gain 
of each amplifier is calculated. For this measurement, the gain is 0.862 mV/pA with a standard 
deviation of 0.034 mV/pA.  
 
Figure 2.6: Chip’s output waveforms show a multiplexed output of 32 TIAs for various input 
current levels into Ical from 0 pA to 1000 pA. Each pulse represents the output of a single TIA. 
2019 © IEEE 
2.5.3 Mismatch 
Small differences in transistors’ sizes within the OPA can cause a voltage mismatch 
between the inverting and non-inverting inputs. The mismatch is due to the fabrication process 
variation. Depending on the application, the inverting inputs control the electrode voltage and the 
accuracy of this voltage can be important. Because the CMOS chip designed in this work features 
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1024 OPAs, the matching performance is worth evaluating. To test this, the array elements are 
programmed to unity gain mode and individually connected to the external electrode so that a 
simple mismatch measurement could be performed. As discussed in Section 2.3.4 and shown in 
Fig. 2.3, unity gain mode connects the OPA’s output directly to the inverting input. The non-
inverting input is held at Vpos, and the output voltage is measured at the ExConE. If the OPAs have 
no mismatch, every OPA will produce exactly Vpos at its output.  
 
Figure 2.7 The current-to-voltage and mismatch characteristics of TIAs. (a) For each input current 
between 0 pA – 1000 pA, TIAs’ outputs are plotted for both high-gain mode and low-gain mode. 
Based on the linear fittings, the transimpedance gains of each mode are 0.86 mV/pA and 7.00 
mV/pA, for low-gain and high-gain modes, respectively. Linearity fittings indicate a high-quality 
linearity. The error bars are used to show the standard deviation of 32 TIAs. The dashed line shows 
the linear fits. The line’s equation is 𝑉𝑜𝑢𝑡 = 𝑎 + 𝑏 ∙ 𝐼𝑐𝑎𝑙, where a = 1.03 V, b = 0.86 mV/pA for 
the low-gain mode, and a = 1.13 V, b = 7.00 mV/pA for the high-gain mode. (b) The voltage 
mismatch of each TIA for the entire array is 1.65 mV, which is a small variation due to the closely-
matching transistor size (input transistor and load transistor). 2019 © IEEE 
A custom-made LabVIEW program is used to control a National Instruments data 
acquisition system automating the SRAM programming and measurement of each individual array 
element’s output as quickly as possible to reduce deviation due to environmental variables such as 
temperature. Each measurement is used to plot a histogram of output voltage measured at the 
ExConE (Fig. 2.7b). The measurement results in a mean output voltage of 1.005 V and a mismatch 
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standard deviation of 1.65 mV for the entire 1024 TIAs. Mainly, the large area investment to ML,k 
and Mk in each OPA (Fig. 2.2) contributes to the small deviation.  
2.5.4 Bandwidth 
In operating the TIA design, it is ideal to have the dominant pole of the transimpedance 
measurement to be determined by the sinc() function created by the current integration (discussed 
in Section 2.4.1) This can only be achieved if the other poles from the OPA and M9 (in Fig. 2.3) 
are higher than the pole from the sinc() function. The pole from the sinc() function is a function of 
the integration window size based on Eq. 2.15,  




   
Thus, the pole can be determined based on the following expression, 
 𝑠𝑖𝑛(𝑓𝐵𝑊 ∙ 𝜋 ∙ 𝑡𝑖𝑛𝑡) −
1
2
∙ 𝑓𝐵𝑊 ∙ 𝜋 ∙ 𝑡𝑖𝑛𝑡 = 0. (2.18) 
   
In the case when tint is 100 μs, fBW is ~4.43 kHz. So long as the other poles do not fall below 
4.43 kHz, the dominant pole of this TIA design is the pole from the sinc() function.  
The bandwidth of the half-shared TIA is measured using three different bias currents, 36.8 
nA, 45.9 nA, and 55.4 nA, for each TIA. Phase compensation is also enabled. Vpos is set to 1 V. A 
TIA is set to connect to ExConE, and the ExConE terminal is connected through a 1 MΩ resistor 
to an analog output of a National Instruments data acquisition unit, allowing for the generation of 
an AC sinusoid current to be applied to the amplifier. Various frequencies are input while the TIA 
outputs are measured and plotted as shown in Fig. 2.8. When tint is set to 100 μs, the TIA produces 
the expected ~4.4 kHz bandwidth as well as the expected sinc2() aliasing sidelobes caused by the 
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integration period. For all three measurements, no observable difference is shown indicating that 
for any tested biasing levels, the OPA’s pole remains higher than 4.4 kHz. 
2.5.5 Crosstalk 
A major concern for the half-sharing concept is crosstalk between shared channels. 
Although the small-signal analysis from section 2.3.2 shows that the design should not suffer from 
crosstalk, a measurement is presented in Fig. 2.9. For this measurement, row one columns one 
through four are measured. A 100 Hz sine wave of 400 μV peak-to-peak is injected into the chip’s 
ExConE through a 1 MΩ resistor to produce a 400 pA peak-to-peak current signal. The row one 
column one TIA is configured to connect to ExConE so the TIA received this current input. 
Columns two, three, and four exhibit little to no crosstalk from the 100 Hz signal as demonstrated 
by Fig. 2.9. The noise floor discrepancy between the four channels is caused by parasitic 
capacitance being added to the input of the amplifier for column one due to its connection to 
ExConE and the wire leading to the signal generator. 
2.6 Conclusion 
In this chapter, we are presenting a simple half-shared amplifier structure which can be 
used for large-scale recordings. Analytical evaluation as well as simulation, and measurement of 
the fabricated circuit are discussed in detail to show the efficacy of the half-shared design and how 
it can scale into a large array without a significant trade-off. Many similar arrays require more die 
area for their amplifiers [34], [38], [39], [42], [49], [57]. Several arrays have increased throughput 




Figure 2.8: Frequency response showing the bandwidth of the TIA at different subthreshold 
biasing levels, 36.8 nA, 45.9 nA, and 55.4 nA. All recordings show near 4.4 kHz bandwidth which 
is caused by the dominant pole generated by the current integration performed at 10 kHz. This 
measurement indicates at any given biasing levels, the dominant pole is produced by the sinc() 
function, instead of the pole from the OPA. 2019 © IEEE 
count, but a low amplifier count, disabling simultaneous full-array measurement [39], [42], [57]. 
This work builds on previous work and has a high electrode count, with simultaneous full-array 
measurement, enabled by the half-shared architecture. The performance of the array is compared 
with other similar arrays in Table 2-1. As discussed in Section 2.3.2, the measurement of each TIA 
does not suffer from crosstalk because the gain is completely independent (Eq. 2.9). One notable 
trade-off is the reduced dynamic range on each inverting input, due to the elevated Vcom. A 
simulation method is presented which can closely estimate the noise performance of a non-
stationary circuit, which has been traditionally difficult to analyze in the frequency domain. The 
transimpedance gain, mismatch performance, bandwidth, and crosstalk performance are measured 
from the fabricated circuit to validate the performance. This minimal deviation in mismatch will 
allow this CMOS device to be useful for most biosensor applications, including single-cell 
amperometry and nanopore-based nucleic acid measurements. It is interesting to note that, the 
common-mode rejection ratio (CMRR) of current-measurement amplifiers is not often discussed  
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Figure 2.9: Measurement of a half-shared block’s crosstalk performance. A 100 Hz signal is 
injected into column 1 via ExConE, the three shared amplifiers show a heavily attenuated signal 
present at 100 Hz. The rise in noise floor between column 1 and the others is due to the extra 
capacitance noise caused by the connection to ExConE and the wire to the signal generator. 2019 
© IEEE 
because the current signal source does not typically carry common-mode signals, in contrast to the 
voltage sources which almost always have a common-mode signal. However, the implication of 
the sharing structure to CMRR is worth studying and we are planning on conducting a future 
research project to investigate the CMRR of a TIA and how it can be quantified in both analytical 
and experimental settings. 
Table 2-1: Comparison to Similar Amplifier Arrays 2019 © IEEE 
Reference [49] [42] [57] [34] [39] [38] This Work [8] 
Technology Node 0.5 μm 0.18 μm 0.5 µm 0.5 μm 0.13 μm 0.18 μm 0.35 μm 
Die Size - 12 mm × 8.9 mm 2.5 mm × 2.5 mm 3 mm × 3 mm 3 mm × 2 mm 5 mm × 2.65 mm 5 mm × 5 mm 
Number of Electrodes 25 59760 100 100 1024 200 1024 
Amplifier Size 525 μm2 ≥0.04 mm2 0.06 mm2 900 μm2 8000 μm2 0.03 mm2 90 μm2 
Simultaneous Channels 25 28 25 (4 to 1 multiplex) 100 4 200 1024 
Noise performance ~ 110 fARMS 
120 pARMS 
 
7.2 pARMS ~ 100 fARMS 56 pARMS 
480 fARMS at 110 
Hz filtered 
415 fARMS 
Bandwidth 2 kHz 16 kHz 11.5 kHz ~1 kHz 700 Hz 110 Hz - 10 kHz 4.4 kHz 
Total Power - 86 mW 2.1 mW - - 3.21 mW 12.5 mW 
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The presented method for reducing the die area required for OPAs in TIAs by half-sharing 
is an effective technique as demonstrated by measurements taken from the fabricated 0.35 μm 
CMOS chip. A four-way half-shared OPA scheme has proven to enable the miniaturization of 32 
TIAs into the same space that would traditionally only be able to fit 17 TIAs, which is nearly 50% 
area reduction while retaining the similar performance. This enables future chips to be designed 







CHAPTER 3:  PARALLEL 1024-CH CYCLIC VOLTAMMETRY FOR CMOS 
ELECTROCHEMICAL DETECTOR ARRAY CHARACTERIZATION 
3.1 Chapter Notes 
In this chapter, an electrochemical detector array was developed for parallel 1024 cyclic 
voltammetry recordings. Cyclic voltammetry, an electrochemical recording technique which 
monitors the electrochemical reactions at an electrode while sweeping the electrode potential, can 
reveal the nanoscopic contaminations of the electrode array which are not visible using a 
microscope. The electrode array can be contaminated after photolithography processing or by 
molecule adsorption. To remove this contamination the electrodes are treated with plasma to 
descum the surface of the electrode. Cyclic voltammetry can be used to examine the quality of 
electrochemical electrodes by measuring the double-layer capacitance that forms at the electrode-
electrolyte interface as this capacitance is directly related to the effective area of the electrodes. 
Additionally, the bipolar capabilities for measuring both negative and positive electrochemical 
currents due to reduction and oxidation reactions are discussed in this chapter. The work described 
in this chapter was completed with Geoffrey Mulberry and Brian N. Kim *.  
3.2 Introduction 
Large-scale microelectrode arrays (MEA) offer high spatiotemporal resolution for 
electrophysiology studies. MEAs have been useful in enhancing the spatial resolution of 
electrochemical recordings, such as mapping the level of H2O2 in relation to neurological diseases 
in a brain slice [31], electrochemical imaging of redox molecules diffusing across an MEA [32], 
 
* In this chapter, we use material published in IEEE Sensors Journal, 2020 [115] 
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and imaging of metabolites in biofilms [33]. Large-scale MEA is especially useful in single-cell 
electrophysiology in which a large number of simultaneous recordings take place in order to 
account for heterogeneity in the characteristics of quantal release among the cell population [25]. 
For these reasons, high-throughput simultaneous measurements from a large number of cells 
would result in a tremendous benefit in enabling rapid studies of neurodegenerative disorders, the 
effects of therapies as well as new drug discoveries that target neurotransmitter release. Significant 
cost reduction in the single-cell electrophysiological analysis will also allow the evaluation of 
emerging treatments for side effects on molecular and cellular levels before it is clinically used. 
A large number of electrodes in the MEA must be connected to external electronic 
amplifiers for signal amplification and processing. The use of external amplifiers becomes 
prohibitively expensive as the number of simultaneous recordings grows (for single-cell 
electrophysiology ~$15,000 per amplifier), but more importantly, it sets a limit on the total number 
of electrodes in an array because the external wiring becomes impractical. To resolve this 
challenge, complementary metal-oxide-silicon (CMOS) chips which monolithically integrate an 
amplifier for every on-chip electrode can be used. This method drastically lowers the cost per 
amplifier and removes the need for external wiring because the on-chip electrode and on-chip 
amplifier establish a connection within the chip. Therefore, the monolithic CMOS-based MEA 
opens the opportunity to increase the electrode count of an MEA to above 1000s. Previously, we 
have developed a monolithic CMOS-based MEA [24], [51], [61] using a 0.35-µm CMOS process 
for electrochemically measuring neurotransmitter secretions from single cells. We designed high-
quality transimpedance amplifiers which can measure transient amperometric currents, resulted 
from the quantal dopamine release with sub-millisecond time resolution and pA current resolution. 
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Half-shared operational amplifiers were designed to maximize the number of amplifiers that can 
fit into a single CMOS chip to 1024 amplifiers, arranged in 32 columns × 32 rows. Measurements 
from the chip revealed low RMS amplifier noise levels ~400 fA at a 10-kHz sampling rate [24]. 
The noise performance of individual amplifiers in the CMOS chip closely matched that of high-
end electrophysiology amplifiers [24], [34], [51], [61].  
The quality control of individual electrodes (sensitivity and other electrical properties of 
electrode-electrolyte interface) becomes difficult as the number of electrodes increases beyond 
1000. Microelectrodes are prone to damage or contamination which can affect the sensitivity and 
background noise. This is especially true if the device is made reusable and the device is used 
repeatedly. Therefore, the quality of microelectrodes must be individually evaluated after 
fabrication or repeated use by characterizing the electrodes for possible contamination and its 
effective surface area. This evaluation step is crucial to perform controlled analytical experiments 
using the well-characterized electrodes [57], [59], [62]. Because nanoscopic contaminations are 
not visible under the microscope, one of the effective ways of characterizing is using cyclic 
voltammetry (CV) which monitors the electrochemical reaction of the electrode while sweeping 
the applied potential (Fig. 3.1a). As such, it can be used to study various characteristics of the 
electrode, such as its impedance as well as sensitivity to oxidation and reduction reactions [57], 
[59], [62]. The large portion of the measured impedance is from the double-layer capacitance, 
created by the interface created between an electrode and the electrolyte, which is proportional to 
the effective surface area of the electrode-electrolyte interface (Fig. 3.1b). When the electrode is 
contaminated, the effective area to interface with the electrolyte is reduced, diminishing the 
sensitivity of the electrode. As the contamination is removed from the surface of the electrode, the 
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increased area of the electrode-electrolyte interface can be measured through the larger double-
layer capacitance by CV (Fig. 3.1c). In order to evaluate a large electrode array with 1000s of  
 
Figure 3.1: Double-layer capacitance and cyclic voltammetry progression of a contaminated 
electrode. (a) The electrolytic solution put on the CMOS electrochemical device introduces ions 
to the electrode. (b) The electrode is held at a potential for electrochemical measurements, 
attracting oppositely charged ions in the electrolytic solution and creating a double-layer 
capacitance at the electrode-electrolyte interface. (c) A contaminated electrode exhibits less 
sensitivity compared to a pristine electrode. As the electrode is cleaned, the progression of the 
response shows an increase in sensitivity. 2020 © IEEE 
electrodes, parallel CV can be performed to collect the electrode-electrolyte interface capacitance 
from 1000s of electrodes simultaneously. This way the researcher can quickly determine the 
quality of the electrode array and apply an appropriate cleaning procedure, such as short piranha 
etching or plasma etching, before reevaluating the electrode quality until satisfactory.  
In this chapter, we present the design of a monolithic CMOS-based MEA which has the 
parallel CV capability to perform the characterization of the integrated electrode array. 
Characterization of the electrode array reveals the state of the surface of individual electrodes. 
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Also, the effectiveness of plasma treatment towards removing contaminants is quantified through 
characterization of the electrode. In this chapter, electrode characterization is performed on the 
monolithic CMOS electrochemical detector array using parallel CV measurements. In Section 3.3, 
the design and performance of the designed bipolar transimpedance amplifier (TIA) are discussed 
as well as the methodology used to integrate the TIA into an electrochemical detector array. In 
Section 3.4, we discuss the post-CMOS processing used to integrate the electrodes and insulation 
onto the CMOS chip as well as parallel CV measurements on an electrode array. In Section 3.5, 
we discuss the characterization of the integrated electrode array on the monolithic CMOS device 
using CV before and after a plasma cleaning process.  
3.3 Design of Bipolar Transimpedance Amplifier 
To identify oxidation and reduction reactions using CV, bipolar current measurement is 
required. In this section, we detail the design of a bipolar TIA and its integration into a 1024 
electrochemical detector array which enables CV measurements.  
3.3.1 Bipolar Capacitive Transimpedance Amplifier 
A TIA design based on the regulated cascode amplifier allows for a high-injection 
efficiency of input current which is beneficial in measuring small picoampere currents [49] (Fig. 
3.2). Our TIA design uses an integrating capacitor to integrate the input current and convert it to 
voltage using the transimpedance gain. A TIA with a regulated cascode cannot inherently measure 
bipolar current because the cascode transistor only allows for a downward current direction. To 
enable bipolar measurement, we introduced a DC offset (Ioffset) to the input of the TIA (Fig. 3.2a). 
With Ioffset introduced as a baseline measurement, the current from electrochemical reactions at the 
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electrode (Ielect) can be either positive (+Ielect) or negative (-Ielect) due to oxidation or reduction 
respectively. Power consumption and area of the amplifier is minimized by using a simple design 
using five transistors for the operational amplifier (OPA) [24]. Negative feedback through the 
cascode transistor regulates the potential of the electrode to be the same as the non-inverting input 
Vpos. As the total current (Iint) is integrated onto the integration capacitor (Cint), the voltage of the 
readout node Vout is reduced. At a periodic interval (Δt), the total voltage drop is readout from the 
amplifier and Cint is reset during readout to begin the next integration cycle. This periodic interval 
determines the sampling rate of the amplifier. To achieve a 10 kS/s sampling rate, the period 
readout interval is 100 µs. In the absence of electrochemical reactions at the electrode, only Ioffset 
is integrated resulting in a readout of ΔVoffset (Fig. 3.2a). During oxidation reactions, electrons are 
being released into the electrode, creating a current entering the electrode node which results in an 
integration current above the offset of Iint = Ioffset + Ielect. The total integrated current is larger during 
oxidation, resulting in a larger readout of Δ(Voffset + Velect) (Fig. 3.2b). Conversely, in reduction 
reactions electrons are being taken from the electrode resulting in a total integration current below 
the offset of Iint = Ioffset – Ielect. This reduction in integration will result in a smaller readout of 
Δ(Voffset – Velect) (Fig. 3.2c) during reduction reactions. To sustain the negative feedback of the 
amplifier, Ielect can be as low as -Ioffset before the TIA effectively turns off. The TIA’s 
transimpedance gain is determined by both Cint, estimated to be 116 fF, and Δt. Knowing the 
transimpedance gain, the bipolar dynamic range of the TIA is -Ioffset to + (Cint×(VDD-Vpos)/Δt) – 
Ioffset. With a VDD of 3.3 V, Vpos of 1.0 V, Ioffset of 700 pA, Cint of 116 fF, and Δt of 100 µs, the 
dynamic range is -700 pA – 1968 pA.  
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Figure 3.2: Designed bipolar capacitive TIA. (a) In the absence of electrons transferred to/from 
the electrode, only Ioffset integrated and ΔVoffset is readout. (b) During oxidation reactions, the 
current integrated is increased to Ioffset + Ielect, increasing the readout to Δ(Voffset + Velect). (c) 
During reduction reactions, the current integrated is decreased to Ioffset - Ielect, reducing the 
readout to Δ(Voffset - Velect). 2020 © IEEE 
3.3.2 Bipolar Measurements and Characteristics 
To validate the bipolar measurement functionality of the designed amplifier, an external 
current with both positive and negative polarity is injected into the electrode node of the amplifier 
while Ioffset remains constant. The external current is injected by connecting an external l-GΩ 
resistor to the electrode node and applying a DC voltage to the other terminal of the resistor. 
Because the voltage at the electrode node is regulated through the feedback, the voltage drop across 
the resistor can be precisely controlled for current injection into the TIA. The linearity of the 
amplifier’s output is studied by applying various levels of bipolar current. For this particular 
experiment, the non-inverting input Vpos, used to set the electrode potential, is set to 1.0 V. The 
external input current ranges from -700 pA – 700 pA by applying the DC voltage drop of -0.7 V – 
0.7 V on the external resistor. The output of the amplifier, as the voltage applied to the 1-GΩ 
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resistor is changed by a small increment every 5 seconds, is shown in Fig. 3.3a and the reference 
of 0 pA corresponds to the integration of only the Ioffset current, set to 700 pA. The recording 
showed a successful demonstration of bipolar transimpedance measurements. By mapping the 
output voltage versus the injected current, the linearity of the TIA can be determined as shown in 
Fig. 3.3b. The fit shown in the figure gives a transimpedance gain of 0.679 mV/pA with a 
coefficient of determination, R2, of 0.998, indicating a high level of linearity for bipolar current 
measurement from -700 pA to 700 pA.  
 
Figure 3.3: Bipolar current measurement of the designed TIA (a) Voltage readout of the TIA at 
different levels of current injected into the electrode. (b) Linear curve fitting illustrating the input 
current vs output voltage linearity. The TIA used exhibits a transimpedance gain of 0.679 mV/pA 
with an R2 value of 0.998, indicating the highly linear performance of the TIA. 2020 © IEEE 
Further characterization of the amplifier’s bipolar capabilities is studied by recording 
alternating signals. Alternating current is injected into the electrode node using the same method 
as above. A 1-MΩ resistor is chosen for this experiment to remove the influence of a zero in the 
frequency response to the circuit. Most component resistors have a parasitic capacitance near 500-
fF and thus the zero created by the 1- MΩ resistor is ~318 kHz, which is outside of the sampling 
rate of 10 kS. The introduction of a zero can result in an inaccurate measurement by increasing the  
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Figure 3.4: Measurement of alternating picoampere current at different levels of DC injection and 
at frequencies of 10, 100, and 1000 Hz. 2020 © IEEE 
amplitude of the input current and distort the results in the low-frequency range. The tested cases 
are at frequencies of 10, 100, and 1 kHz with each frequency using the same AC amplitude of 
200μV and at super-imposed DC levels of +100pA, 0pA, and -100pA (Fig. 3.4). The recordings 
validate the amplifier’s ability to measure bipolar alternating current at various frequencies.  
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3.3.3 Integration of 1024-ch Amplifier Array  
To integrate an array of amplifiers for parallel electrochemical measurements, a half-shared 
OPA structure is used, which has been previously studied [24], [61]. The purpose of the half-
shared OPA design is to reduce the area required to create a dense sensor array by sharing one 
non-inverting input with multiple inverting inputs (Fig. 3.5). In the presented device, one non-
inverting half of an OPA is shared by groups of 4 TIAs, each of which occupies 30 × 30 µm2. The 
monolithic CMOS device, fabricated in a standard 2-poly 4-metal 0.35-µm process, has an array 
of 32 × 32 electrochemical detectors (Fig. 3.6a).  
The entire array is operated through the application of two clock signals to the internal 
timing circuitry which generates a comprehensive set of clock signals required to achieve 
correlated double sampling, resetting of the integration capacitor in each TIA, and time-division 
multiplexing. To condense the output of the 1024 electrochemical detectors to 32 parallel outputs 
on a column basis, time-division multiplexing is used. The time-division multiplexing staggers the 
readout period, as well as the integration period, of the 32 rows in a column to minimize integration 
deadtime of the array.  
3.4 Cyclic Voltammetry on an Electrode Array 
It is common for semiconductor foundries to fabricate CMOS chips with an aluminum-
copper alloy as the top metal layer. However, aluminum is highly reactive to electrolytic solutions 
and introduces significant offsets and shot noise to electrochemical recordings. To prepare the 
device for electrochemical measurements, post-CMOS processing is used to integrate polarizable 
electrode materials with low reactivity, such as platinum or gold, onto the CMOS chip.  
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Figure 3.5: Half-shared OPA and TIA schematic. The non-inverting half of the OPA is shared 
among multiple TIAs. Each TIA has a dedicated electrode, integration capacitor, and current 
mirror generating Ioffset. 2020 © IEEE 
3.4.1 Monolithic Integration of the Electrode Array 
To integrate the platinum electrode array onto the CMOS chip, photolithography is used to 
perform a lift-off process. The chips are processed individually after they have been attached to a 
coverslip (25 mm × 25 mm) to ease the handling of the small devices (5 mm × 5 mm). After the 
chips have been attached to the coverslips, they are cleaned using acetone, isopropanol, and 
deionized water. For the lift-off process, a sacrificial layer of photoresist is created before metal 
deposition. This layer is created by spin coating, exposing, and developing a negative photoresist, 
NR9-1500PY, on the surface of the chip, removing photoresist where the electrodes will be 
patterned. The electrode materials are then deposited onto the processed chips, starting with the 
deposition of 20 nm of Ti and then 200 nm of Pt through sputtering (AJA Six-Gun Sputtering 
System, AJA International Inc., N Scituate, MA). After the metal is deposited onto the chip’s 
surface, the sacrificial layer of photoresist is removed by rinsing the sample with acetone. Removal 
of the sacrificial layer leaves only the desired electrodes on top of the amplifier array. 
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To prepare the monolithic CMOS device for electrochemical applications such as single-
cell amperometry, a biocompatible epoxy-based photoresist, SU-8 3010, is used to provide 
isolation between the electrodes in the electrochemical detector array (Fig. 3.6b). After the lift-off 
process has been completed, the chips are again cleaned with acetone, isopropanol, and deionized 
water. The SU-8 photoresist is spin coated, exposed, and developed for patterning. The SU-8 
patterns are an array of 15 µm × 15 µm wells atop the electrodes. The SU-8 layer that remains on 
the surface of the monolithic CMOS device is approximately 20 –30 µm thick.  
3.4.2 Cyclic Voltammetry on Individual Electrode 
Cyclic voltammetry is demonstrated by applying a sweeping electrode potential from 1.2 
– 2.0 V in a 20-second period while simultaneously measuring the electrochemical current 
resulting from reactions occurring at the electrode’s surface (Fig. 3.7). Phosphate-buffered saline 
(PBS) (2mL) is placed on the electrode array and an Ag|AgCl reference electrode, which is 
connected to 1.2 V, is placed in the electrolytic solution to form the CV setup. As the potential of 
the integrated electrodes sweep from 1.2 – 2.0 V against the reference of the Ag|AgCl electrode 
that is held at 1.2 V, the resulting differential voltage drop at the electrode-electrolytic interface is 
0 – 0.8 V (Fig. 3.7a), resulting in a CV scan rate of 80 mV/s. To increase the dynamic range for  
the CV measurements, the array is run at a sampling rate of 20 kHz. The time-domain current 
measurements from a representative electrochemical detector (Fig. 3.7b), comprised of a bipolar 
TIA and its platinum electrode, are done with and without PBS on the array. When there is no PBS 
on the array, the voltammogram in grey (Fig. 3.7c) shows a response that is predominantly 
resistive. After placing PBS on the array, the effects of the double-layer capacitance can be seen.  
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Figure 3.6: Photograph of the CMOS chip and the electrochemical detector arrays. (a) 
Microphotograph of the CMOS chip. To operate the array, two clocks are applied to the timing 
circuitry. The readout circuitry consists of the 32-to-1 multiplexers and output buffers to drive off-
chip ADCs. A duplicate array is on the chip for characterization and testing. (b) The cross-sectional 
view of the electrode array and four electrodes with the focal plane set to the top of the insulator 
layer. 2020 © IEEE 
This double-layer capacitance introduces a component to the measured current that reacts to 
change in the applied potential’s slope (Fig. 3.7b). When dealing with a purely capacitive system, 
the capacitance can be found by measuring the current that results from the applied potential’s 
slope through the relationship C = I/(dV/dt). However, the presented system has both resistive and 
capacitive impedance. To remove the influence of current due to resistive impedance, the change 
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in current due to both the positive and negative cycles of the applied potential is examined. To 
maintain an objectiveness, 400 mV is chosen as a standard to review the change in current across 
the electrode array. For our CV setup, there is a change of 800 mV over a 10 s period for both the 
rising and falling cycles of our applied potential, resulting in a dV/dt of 80 mV/s. Examining this 
change in current at 400 mV and the symmetric slope of the applied potential (Fig. 3.7a), we can 
estimate the capacitance using the following Eq. (3.1): 
 







   
For this particular electrode (Fig. 3.7c), the bipolar change in current is 1.19 pA when the 
electrode array is dry and 104.8 pA when there is electrolytic solution on top of the electrodes. 
When the array is dry, the voltammogram exhibits 7 pF of capacitance. When electrolytic solution 
is placed over the array the calculated double-layer capacitance is 660 pF. This significant increase 
in capacitance demonstrates the dominant capacitance for our CV recordings is from the double-
layer capacitance formed by the electrode-electrolyte interface. 
3.5 Parallel Electrode Array Characterization 
To study the quality of the monolithically integrated electrodes, parallel CV is performed 
to characterize individual electrodes. For the designed electrochemical detector array the input Vpos 
is shared across the array, enabling simultaneous CV measurements. When measuring from the 
array of electrodes the setup is as previously described, the integrated electrode is swept from 1.2 
– 2.0 V, the reference electrode is held at 1.2 V in 2 mL of PBS, and the sampling rate of each 
amplifier is 20 kHz.  
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Figure 3.7: CV measurement from one TIA electrode. (a) Applied potential vs the reference 
electrode in the electrolytic solution. (b) Time-domain current measurement from a TIA when the 
device is dry and when PBS is put on the array. (c) Voltammogram of the measured current versus 
the applied potential. The dry measurement is nearly resistive, and the electrolytic measurement 
reveals the double-layer capacitance of the electrode. 2020 © IEEE 
3.5.1 Electrode Surface Cleaning 
After post-CMOS fabrication, cleaning of the electrode surface is required to ensure that 
the surface is pristine for use in electrochemical detections because contamination of the 
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electrode’s surface reduces its effectiveness for electrochemical measurements. An electrode’s 
surface can be contaminated during the photolithography processes as well as through repeated 
use of the electrode for electrochemical measurements. In post-CMOS processing, the last step to 
create an insulation layer using SU-8 has been reported to often leave a thin film on the electrodes 
after development [63], [64]. Also, molecules, such as dopamine, can also adsorb onto the surface 
of the electrode [65], [66] after an electrochemical measurement and reduce the sensitivity of the 
electrode [67]. In this study, we used a plasma cleaner (PDC-32G, Harrick Plasma, Ithaca, NY) to 
remove organic material from the surface of the electrodes using ionized gas.  
3.5.2 Parallel Cyclic Voltammograms 
The resulting voltammograms from one parallel CV recording are shown in Fig. 3.8. The 
levels of contamination of an electrode array can be monitored by measuring the double-layer 
capacitance across the array through parallel CV recordings. As the area of the electrode’s surface 
is contaminated, the effective area that creates an interface between the electrode and the 
electrolyte, the double-layer capacitance, is reduced. Modeling the double-layer capacitance as C 
= εA/d, the reduction of the electrode-electrolytic interface area (A) is directly related to the 
reduction of capacitance. The electrochemical electrode array, which was previously used for 
several experiments involving the oxidization of dopamine, is used for electrode array 
characterization using CV (Fig. 3.8, orange trace). The recorded set of voltammograms is used to 
calculate the double-layer capacitance formed at each electrode-electrolytic interface. The average 
capacitance of the electrode array is 0.47 nF with a standard deviation of 0.14 nF. To remove the 
contaminants, the electrode array is given a 10-minute plasma treatment, and the response of the 
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electrodes is re-characterized (Fig. 3.8, red trace). The mean capacitance of the array after plasma 
treatment is 1.36 nF with a standard deviation of 84.5 pF, nearly tripled compared to the initial 
characterization. The increased mean capacitance reveals that the electrodes could have been 
previously contaminated and plasma treatment improved the surface condition, increasing the area 
of the electrode-electrolyte interface and thus the double-layer capacitance.  
 
Figure 3.8: CV recordings from an electrode array. (a) A representative CV of an electrode before 
and after 10-min plasma treatment. The electrodes are initially contaminated and exhibit reduced 
sensitivity as shown in the orange lines. (b) The electrode with contamination on the surface can 
have reduced surface area where the plasma treatment is anticipated to increase the surface area 
by etching the contaminant. (c)After plasma treatment, the capacitance of the electrode array is 
increased consistently throughout the array, reflecting the increased surface area. 2020 © IEEE 
3.6 Conclusion 
In this chapter, we study the quality of an electrode array through parallel CV 
measurements, as well as present the design and performance of a bipolar capacitive TIA used in  
a 1024-channel monolithic CMOS device for high-throughput electrochemical recordings. The 
presented capacitive TIA is capable of measuring bipolar current from oxidation and reduction 
reactions through the introduction of a DC offset, Ioffset. The bipolar capabilities of the capacitive 
TIA are demonstrated by measuring alternating current that is injected into the electrode node. 
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Integration of the bipolar capacitive TIA for large-scale parallel electrochemical recordings in a 
1024-channel CMOS device is achieved through the use of the half-shared OPA structure. Through 
post-CMOS processing, the platinum electrode array and the SU-8 insulation is monolithically 
integrated on the CMOS device. To examine the quality of the electrode array after repeated use 
for electrochemical recordings, parallel CV is performed before and after plasma treatment. The 
contaminations on the electrode surface, such as adsorbed molecules or a thin film of photoresist, 
reduce the effective area for the electrode-electrolyte interface and thus the double-layer 
capacitance. After plasma treatment of the electrode array, the capacitance increased substantially, 
indicating that the surface of the electrodes could have been contaminated and plasma treatment 
improved the surface of the electrode, thus increasing the electrode-electrolyte interface and the 
double-layer capacitance. Using parallel CV, characterization of the 1024 electrode array can be 




CHAPTER 4:  MULTIFUNCTIONAL DATA ACQUISITION SYSTEM FOR HIGH-
SPEED 1,024-PIXEL CMOS ELECTROCHEMICAL SENSING 
4.1 Chapter Notes 
Here, we developed a multifunctional data acquisition system that enables high-speed 
1024-pixel CMOS electrochemical imaging. Fast electrochemical imaging of the diffusion of 
dopamine and hydrogen peroxide is recorded at 40,000 frames per second across the 32 × 32 
neurochemical detector array and presented in this chapter. To support the high level of data 
generated by the neurochemical detection array, a custom data acquisition system is designed to 
interface with the high-density neurochemical detection array. The FPGA-based acquisition 
system discussed in this chapter provides an interface to control the neurochemical sensing array 
with a computer. Additionally, the system’s data acquisition capabilities transfer the high-density 
of detected neurochemical signals to a computer for further analysis. The work described in this 
chapter was completed with Matthew A. Crocker and Brian N. Kim. 
4.2 Introduction 
Recent advancements have provided enhanced spatiotemporal resolution for 
electrochemical studies such as the imaging of diffusing electroactive molecules [32], [51], 
detection of toxic metabolites such as pyocyanin [68], [69], and mapping of H2O2 levels, in 
association with neurological diseases, throughout a brain slice [31] using electrochemical sensor 
arrays. Using electrochemical techniques, the redox molecules present in electrochemical studies 
will either release electrons, oxidization, producing a negative current as the electrons are accepted 
by the electrode, or will take electrons from the electrode, reduction, producing a positive current. 
56 
For example, the presence of neurotransmitters, such as dopamine, can be studied by direct 
measurement of the released electrons during an oxidation reaction at an electrode. The dynamics 
of redox molecule diffusion may only last milliseconds to microseconds, as such, the high temporal 
resolution provided by electrochemical recordings provides a unique advantage in capturing details 
of the reaction. Additionally, it is possible to be highly specific to, and highly sensitive of, the 
electroactive molecules using electrochemical detection techniques. To further enhance the high 
specificity and temporal resolution of electrochemical recordings, the miniaturization and 
parallelization of the electronics and sensors is prevalent in emerging devices that explore the 
integration of microelectrode arrays (MEA) and complementary metal-oxide-semiconductor 
(CMOS) technology. The parallelization of the sensor array enables the construction of spatial data 
sets based on the sensor array’s geometric arrangement. However, as the electrode count of MEAs 
increases, the expansion of parallel electrochemical recordings introduces an instrumentation 
challenge. Direct wiring of electrodes to their corresponding amplifiers becomes impractical and 
using commercially available amplifiers is costly. To support the increasing throughput of 
electrochemical recordings, CMOS technology is being explored as an interface, as it can provide 
arrays of readout circuitry which amplify and process the electrochemical signals detected by 
MEAs. Through on-chip integration of MEAs, interconnections are simplified and readout 
circuitry is scalable, allowing large-scale electrochemical sensor arrays on small silicon chips. 
Recently developed devices include an array of 59,760 electrodes capable of up to 2048 
simultaneous recordings [36], [42], an array of 10 × 20 electrodes with the capability of performing 
voltammetry as well as amperometry [38], a 32 × 32 array that provides electrochemical images 
57 
at 90 frames per second [32], and an array of 100 electrodes for up to 100 parallel recordings of 
neurotransmitter release from chromaffin cells [34], [64].  
The monolithic integration of the electrochemical sensors simplifies the connections 
between the electrodes and the readout circuitry, but an external data acquisition system remains 
necessary to support the operation of the complex functionality of the sensor arrays and transfer 
of the recorded electrochemical signals to a computer for storage and analysis. The external system 
can be simplified through the integration of analog-to-digital converters (ADCs) in the CMOS 
chip. However, the integration of ADCs in the CMOS chip requires a large area, as such, it can be 
preferable to instead use external ADCs. Additionally, external ADCs have additional benefits, 
such as cost-effectiveness, as a direct result of the sensors generally being treated as single-use 
devices, due to their need to make direct contact with the biological or chemical substances being 
investigated. Future advancements in biotechnology will require high-throughput data acquisition 
to enable high-throughput gene sequencing [35], [70], high-throughput drug screening studies 
[39], [71], high density brain-machine interfacing [72]–[74], and high-throughput single-cell 
electrophysiology [24], [34], [64]. To support high-throughput applications, the external 
acquisition system must support fast analog-to-digital conversion, extensive data transmission, and 
highly parallelized signal processing. For an electrochemical imaging device with 1,000 sensors 
operating at 40,000 frames per second, a minimum cumulative sampling rate of 40 million samples 
per second (S/s) is required. If 16-bit ADCs are used for digitization, 2 bytes are created per sample 
and the minimum data transmission rate is 80 Mbytes per second (MB/s). Redundant sampling can 
improve the noise and accuracy of recorded electrochemical signals, however, the minimum data 
transmission speed will increase by a factor of two or more [34]. A high-performance acquisition 
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system was designed using commercially available data acquisition modules and is capable of 
digitizing 16 analog inputs at a maximum sampling rate of 120 MS/s at a 16-bit resolution [75], 
[76]. However, this system is very costly and lacks a sufficient number of analog inputs for a high-
throughput CMOS device used for parallel recordings of neurotransmitter release from single cells 
[24], [51], [61]. As an alternative to commercially available systems, low-cost data acquisition 
systems have been presented using Arduinos [77] and custom acquisition systems controlled by 
microcontrollers [78] or field-programmable gate arrays (FPGAs) [79], [80]. However, the 
sampling rates of these alternative systems are inadequate for high-throughput electrochemical 
imaging with fine temporal resolution. To support the data transmission demands for high-
throughput applications, the selected interface must be taken into account. Common interfaces 
used for data acquisition systems are universal serial bus (USB), peripheral component 
interconnect (PCI), and PCI Express (PCIe). Among these interfaces, USB is the most accessible 
due to its availability on virtually all desktop computers as well as laptops, whereas PCI and PCIe 
interfaces are limited on desktop computers and require external adapters for use on laptops. For 
high-throughput electrochemical imaging, the growing prevalence of the USB 3.0 interface 
provides sufficient data transmission at up to 625 MB/s and broadens the applications of data 
acquisition systems outside of well-equipped research laboratories. By using the power delivered 
through the USB interface, ranging from 4.5 watts (W) for USB 3.0 and up to 15 W for type-C, 
the data acquisition systems can be designed for applications requiring portable high-performance 
devices.  
In this chapter, we present the design of an electrochemical sensing platform that is capable 
of 1024 simultaneous electrochemical recordings at a frame rate of 40,000 per second, one of the 
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fastest devices reported to date with high spatial resolution. The designed system provides 
significant benefits for studies that require high-throughput and high spatial and/or temporal 
resolution, such as high-throughput single-cell amperometry to study the mechanisms of 
neurological diseases, the mechanisms of vesicle secretion, and the dynamics of neurotransmitter 
release. In the following sections, the design of the 1024-pixel electrochemical imaging sensor will 
be presented alongside the custom data acquisition system that enables the frame rate of 40,000 
frames per second. In section 4.3.1 the design of the CMOS electrochemical detector is discussed, 
while in section 4.3.2 the post-processing stage of the CMOS chip is discussed. Section 4.3.3 
discusses the packaging of the CMOS chip to ensure the device is both biocompatible and 
waterproof. In section 4.3.4 the data acquisition system and its parts are discussed, while in section 
4.3.5 the design of the FPGA architecture is discussed. Section 4.3.6 presents the experiment taken 
to characterize the noise performance of the data acquisition system and 4.3.7 presents the 
experimental procedures for the electrochemical imaging of dopamine and H2O2 diffusion using 
the designed electrochemical imaging sensor. Section 4.4.1 discusses the noise characterization of 
the data acquisition system and section 4.4.2 discusses the successful imaging of dopamine and 
hydrogen peroxide diffusing over the electrochemical sensor array. 
4.3 Material and methods 
4.3.1 CMOS Electrochemical Detector Design 
For two-dimensional imaging of dopamine diffusion, a CMOS device with an 
electrochemical detector array is designed to measure the electrochemical signals from 
electroactive molecules diffusing on the surface of the chip in parallel. The signals from these 
molecules are small currents that range from pA to nA. To record these small currents, an 
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electrochemical detector is designed which consists of an integration capacitor-based 
transimpedance amplifier (TIA) and an on-chip electrode as described in section 4.3.2 (Fig. 4.1).  
 
Figure 4.1: Overview of the electrochemical imaging system’s architecture. 
To set the voltage of the electrode to a redox potential for electrochemical experiments, the 
feedback through the operational amplifier (OPA) regulates the voltage of the electrode to be equal 
to the OPA’s input, Vpos. As electrons flow through the electrode by way of oxidation or reduction, 
the current resulting from an electrochemical reaction is integrated onto a capacitor. To minimize 
the reduction of the electrochemical current due to the input impedance of the TIA, a regulated 
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cascode topology is used for high injection efficiency [49]. The integration of current on the 
capacitor results in a reduction in voltage at the TIA’s readout node. The voltage at the readout 
node is read periodically and the voltage of the integration capacitor is reset during the readout 
phase to start the next integration cycle. The length of the periodic readout and subsequent reset 
of the integration capacitor determines the sampling rate of the TIA. To achieve a 40 kS/s sampling 
rate, the periodic readout occurs every 25 µs. The designed TIA occupies an area of 30 × 30 µm2 
and also includes a 1-bit static random-access memory (SRAM) to enable testing circuitry or 
adjustment of the total integration capacitance, thus changing the current to voltage gain of the 
TIA.  
To enable large-scale electrochemical recordings, the CMOS chip has an array of 32 × 32 
electrochemical detectors. The recordings of the 1024 detectors is reduced to 32 parallel outputs, 
on a column basis, using time-division multiplexing. Time-division multiplexing sequentially 
staggers the readout period of the rows such that one detector is being read while the rest are 
integrating, eliminating dead time due to readout [24]. To operate the integrating TIAs and 
multiplex the 1024 electrochemical detectors, the timing circuits are designed to generate all 
necessary signals using two external clock inputs. To send the electrochemical recordings to a 
computer for analysis, the CMOS chip interfaces with external ADCs in the FPGA-based data 
acquisition system described in Section 4.3.4. The multiplexed outputs of the detector array are 
fed into output buffers in order to drive the capacitive load from the output lines, bonding pads, 
and the input capacitance of the ADCs. The CMOS electrochemical detector array is designed 
using Cadence Virtuoso Analog Design Environment and fabricated using a standard 2-poly 4-
metal 0.35 µm CMOS process.  
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4.3.2 Post-CMOS Processing 
A common material used for the top metal layer for CMOS fabrication is an 
aluminum/copper alloy, which is reactive to solutions used for electrochemical experiments and is 
inadequate for applications requiring high signal-to-noise performance. To achieve a high signal-
to-noise ratio, polarizable electrode materials, such as platinum or gold, are used because of their 
low reactivity to electrolytic solutions. Through post-CMOS processing, an MEA using a 
polarizable material, platinum, is integrated onto the surface of the CMOS chip. To integrate the 
MEA onto the device, a lift-off process is used, this process is accomplished through 
photolithography using negative photoresist. The lift-off process starts by creating a sacrificial 
layer of photoresist, patterning the desired electrode patterns into the sacrificial layer permitting 
access to the surface of the CMOS chip, deposition of metal materials, and removal of the 
sacrificial layer, leaving only the desired electrode patterns on the surface of the device. Prior to 
the photolithography process, each CMOS die (5 mm × 5 mm) is bonded to a coverslip (25 mm × 
25 mm) using epoxy in order to reduce the complications of handling small samples for post-
CMOS processing. The bonded die is then cleaned by bathing it in acetone, isopropanol, and then 
DI water. The bonded die is spin coated with a negative photoresist, NR9-1500PY, to cover the 
surface of the device. The device is then put into a contact aligner (EVG 620, EV Group, St. Florian 
am Inn, Austria) with a custom-designed photomask to correctly position the desired MEA pattern 
on the CMOS chip. The chip is exposed to UV light in the aligner and then developed to remove 
photoresist from the surface of the device where metal deposition is desired. To integrate the 
platinum MEA, 20 nm of Ti is first deposited to act as an adhesion layer between the Al/Cu and 
Pt, then 200 nm of Pt is deposited using a sputtering machine (AJA Six-Gun Sputtering System, 
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AJA International Inc., N Scituate, MA). To remove the sacrificial layer of photoresist, the dies 
are repeatedly rinsed with acetone and the layer of NR9 photoresist washes away. The metal that 
is deposited on top of the NR9 layer is removed from the device completely, leaving only the 
desired MEA as patterned during UV exposure. To prepare the CMOS device for single-cell 
electrophysiology [24], a biocompatible epoxy-based photoresist, SU-8, well structure is created 
atop each electrode throughout the array to permit one cell to sit atop each electrode for single-cell 
recordings and to reduce the effects of adjacent electrodes and cells [24]. The wells are created 
through a subsequent photolithography process using SU-8 3010 negative photoresist. After the 
lift-off process, the dies are cleaned by bathing the chips in acetone, isopropanol, and then DI 
water. The chip is spin coated to cover the CMOS chip with SU-8 photoresist, exposed to UV light 
using a contact aligner (EVG 620, EV Group, St. Florian am Inn, Austria), and a second image on 
the designed photomask containing an array of well structures that are 15 μm × 15 μm in size. 
Finally, the exposed SU-8 is developed to remove undesired SU-8 from the surface of the CMOS 
chip and permit access to the platinum electrodes throughout the MEA. 
4.3.3 Biocompatible Packaging 
After the MEA is integrated onto the CMOS chip, it is bonded onto a custom-designed 
PCB die holder using epoxy. After the epoxy has cured, the pads on the CMOS chip are wire 
bonded to the PCB pads to provide an interface between the CMOS electrochemical detector array 
and the external data acquisition system. To protect the wire bonds when handling the device, and 
from liquids during electrochemical experiments, a 3D-printed well made of acrylonitrile 
butadiene styrene (ABS) plastic is coated with polydimethylsiloxane (PDMS), for waterproofing 
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and biocompatibility, and then bonded to the surface of the CMOS chip using additional PDMS. 
The custom-designed ABS well provides an opening to access the surface of the CMOS device 
and accommodates 2mL of liquid for electrochemical experiments [24].  
4.3.4 Design of FPGA-based Data Acquisition System 
To operate the integration and readout functions of the electrochemical detector array and 
to read the data output from the array, an FPGA-based data acquisition system is developed to 
interface with the CMOS chip. The acquisition systems includes 32 ADCs with 16-bit resolution, 
1 adjustable regulator, 16 digital inputs and outputs (DIO), and a USB 3.0 SuperSpeed interface. 
The acquisition system consists of an Opal Kelly FPGA board and a custom-designed PCB (Fig. 
4.2). On the FPGA board, there is a Cypress FX3 chip that provides a SuperSpeed USB 3.0 
interface that can receive commands to control the IO of the Kintex-7 FPGA chip. The FPGA chip 
generates the DIO used to operate the electrochemical detector array, such as providing the clock 
signals for the CMOS’ internal timing circuitry, and receives the parallel streams of data from the 
32 parallel ADCs. To achieve synchronous operation of the electrochemical detector array and the 
ADCs, the FPGA generates all clock signals used throughout the electrochemical sensing system.  
On the custom-designed PCB, there are 16 ADC chips (LTC2323-16, Liner Technology), 
each of which have two embedded ADCs that can individually sample their respective inputs up 
to 5 MS/s, providing 32 high-speed 16-bit ADCs (Fig. 4.2). A 4-pole Low-Pass filter is designed 
using the Sallen-Key topology and is used as an anti-aliasing filter for each ADC. The ADCs 
convert the 32 parallel outputs of the electrochemical detector array to their 16-bit digital 
representations and then sends this data serially to the DIO pins of the FPGA. The received data 
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is then processed and packaged by the FPGA to be transferred to a PC through the USB 3.0 
interface chip.  
 
Figure 4.2: Images of the FPGA-based data acquisition system. (left) The system uses a USB 3.0 
interface to interface with a computer to receive data from the electrochemical imaging array and 
send commands to the FPGA chip, which controls all clock signals and digital IO. (right) 32 
parallel ADCs simultaneously digitize data from the 32 parallel outputs of the electrochemical 
imaging device.  
4.3.5 FPGA Architecture 
The architecture of the FPGA consists of clock generation, shift registers for parallel serial 
streams of data, a first-in, first-out (FIFO) data manager, and a USB 3.0 interface to control the 
functionality of the electrochemical sensing system and send data to a computer (Fig. 4.3). Using 
a 200 MHz oscillator as a master source, the FPGA synchronously generates all of the clocks 
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required to initiate sampling and readout of the ADCs as well as integration and readout of the 
electrochemical detector array. The generated clocks are subdivided from a master clock of 
128MHz into 32 MHz, 2.56 MHz, 1.28 MHz, and 40 kHz. In addition to synchronously running 
the CMOS chip and the ADCs, the generated clocks are also repurposed inside the FPGA to 
operate the input shift registers and the FIFO. The 40 kHz clock initiates the readout for the first 
row in the electrochemical detector array, and the 2.56 MHz clock propagates the readout period 
across the 32 columns to the next row in the array while also returning the previous row to an 
integration period, resulting in an effective frame rate of 40,000 frames per second. With a 2.56 
MHz operation frequency for the CMOS chip, the output rate of the columns results in a 1.28 MHz 
signal. Each of the 32 ADCs sample the 32 parallel CMOS outputs simultaneously at 1.28 MHz  
 
Figure 4.3: An overview of the FPGA’s architecture. Data from the ADCs is serially output to 32 
parallel pins on the FPGA chip, where it is processed and packaged before being transferred to the 
computer through the USB 3.0 interface. The data is stored in a FIFO queue until the data is 
requested through the FPGA’s API, once a request is made the data will be transmitted through 
the USB 3.0 interface. 
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and the 16-bit digital conversions are output from the ADCs in serial data streams at a rate of 32 
MHz. The data from the ADCs are input to shift registers in the FPGA to allow parallel processing 
of the data. The data from the ADCs is then packaged through column-based multiplexing so that 
the first data package contains the data from column 1, the next package contains data from column 
2, and so on. The packaged data is then passed into a FIFO data queue that continuously fills until 
the computer asks for data from the FPGA via USB 3.0 interface. The connected computer uses a 
C++ program to send the system reset signals and initialize the system prior to data collection. To 
obtain the data stored in the FIFO, requests are made through the FPGA’s application 
programming interface (API). The program allows the desired data amount to be specified and 
multiple sets of data to be continuously transferred, useful for multiple successive experiments. 
4.3.6 Characterization of Noise and Performance 
To characterize the noise performance of the inputs to the data acquisition system, a linear 
voltage regulator is powered by one 9V lithium-ion battery and used as an input to the custom 
PCB, wherein the input is first filtered by a 4-pole anti-aliasing filter and then input into an ADC, 
for our noise characterization. The linear regulator is set to output a voltage of 0.92 V, which is 
the output voltage of the CMOS chip when no current is integrated by the TIA. The input to the 
data acquisition is recorded for ~12s so that the noise spectrum can be examined down to ~0.1 Hz.  
4.3.7 Experimental Procedure for Electrochemical Imaging 
To demonstrate the capabilities of the electrochemical sensor array, the diffusion of 
dopamine and hydrogen peroxide are recorded. For the dopamine diffusion experiment, 1mL of a 
phosphate-buffered saline (PBS) solution is first added to the electrochemical sensor’s well and a 
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reference Ag|AgCl electrode is connected to ground and put in the well. To ensure that no bubbles 
are blocking access to the electrodes throughout the array, preventing an interface between the 
electrode and the electrolytic solution used for electrochemical experiments, the sensor and 
solution is agitated until no bubbles remain. When performing consecutive experiments, the 
electrolytic solutions used are never fully removed from the well to avoid drying of the electrodes, 
thus preventing bubbles from reappearing and blocking the electrode/electrolyte interface. To 
purify the electrolytic solution on the sensor array between experiments, half of the 2mL solution 
(the maximum capacity of the well) in the well is removed, then the remaining solution is 
thoroughly diluted by adding an additional 1 mL of PBS solution into the well, and then 1 mL is 
removed from the well for either another dilution injection or an electrochemical experiment. This 
process is repeated multiple times to dilute the previous electroactive molecule to a non-detectable 
concentration. To obtain a baseline recording of the MEA, a recording with only 1mL of PBS 
solution on the electrochemical sensor is taken to ensure functionality of the array. Then a control 
experiment is performed by injecting 1 mL of PBS into the well. The control experiment is 
performed (data not shown) to ensure that the signals recorded from the later injected redox 
molecules are not a result from a contamination in the PBS or changing influence of the reference 
electrode’s interface with the increasing electrolytic solution volume. When injecting into the well, 
for all experiments, the pipette is pointed into the corner of the well to avoid directly injecting onto 
the electrodes. This prevents signal saturation throughout the array immediately after injection, 
allowing the imaging of redox molecules diffusing across the sensor array. Following the control 
experiment, we record the injection of 1mL of an 800 μM dopamine solution into the well (data 
not shown), and then an injection of 8 mM dopamine solution after cleaning out the well from the 
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800 μM dopamine experiment. For these recordings, amperometry is the electrochemical 
technique used to detect the presence of dopamine throughout the array. The electrode is held at a 
potential of 920 mV, enabling the oxidation of the dopamine molecules. The H2O2 experiment 
follows the same procedure outlined for the dopamine experiments, with the exclusion of an 800 
μM injection. As such, only an 8 mM H2O2 injection experiment is performed for electrochemical 
imaging. 
4.4 Results and Discussion 
4.4.1 Noise Characteristic and Performance 
For the noise characterization of the ADCs in the data acquisition system, the filters setup 
on the custom-designed PCB are 4th order low-pass filters with a cutoff frequency of 1 MHz. The 
noise is characterized at a 1.3 MHz sampling rate, the minimum rate required to operate the CMOS 
imaging sensor at a frame rate of 40 kHz. With the battery-powered voltage input, the recorded 
noise spectral density (NSD) is presented in Fig. 4.4. The filtered noise in the measured density 
starting at 20 kHz is an improvement over a previous acquisition system that was suitable for 
electrochemical imaging using a similar CMOS imaging sensor at a frame rate of 10 kHz with a 
noise density of 1.01 × 10-12 V2/Hz [51]. 
4.4.2 Fast Frame Rate Electrochemical Imaging 
To demonstrate the parallel recording capability of the presented electrochemical sensor 




Figure 4.4: A plot of the noise spectral density versus frequency. 
Dynamic Dopamine Imaging: The dopamine diffusion through the PBS solution and across 
the sensor array can be observed in Fig. 4.5 where the sensor array’s data is presented over a 160 
millisecond period. In the presented figure, the levels have been normalized and are represented 
by the yellow to black gradient, with yellow denoting the largest recorded current levels, which 
directly relates to the amount of dopamine detected by the sensor until it reaches an oxidation 
steady-state. Here the dopamine traverses from the right side to the left side of the sensor array 
and is presented in 9 frames at 20 millisecond intervals. Beyond the time presented in Fig. 4.5, the 
dopamine continues to diffuse across the entire array until roughly all of the sensors report the 
same approximate steady-state levels of oxidation current. Due to the temporal resolution of the 
device, it is capable of capturing events that last at least 1/10th of a millisecond, providing the 
opportunity to observe electrochemical events with very limited lifetimes. In the figure in the top 




Figure 4.5: Dopamine diffusion imaging across the sensor array. 
it diffuses across the array as will be seen in the same area for the hydrogen peroxide diffusion 
results. 
Dynamic Hydrogen Peroxide Imaging: The diffusion of H2O2, at a concentration of 8mM, 
across the sensor array is presented in Fig. 4.6. In the presented diffusion imaging, the H2O2 
diffuses across the sensor array starting from the left. The levels have been normalized and are 
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represented by the purple to blue gradient, with purple denoting the largest recorded current levels, 
which directly relates to the amount of peroxide detected by the sensor until its steady-state point 
is reached. The diffusion of the H2O2 is displayed in 150 millisecond intervals. From the dopamine 
and peroxide imaging results, we see that the sensor array is capable of providing spatiotemporal 
data that can be used to visualize the diffusion of an electroactive molecule across the array. 
 
Figure 4.6: H2O2 diffusion imaging across the electrochemical sensor array. 
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4.5 Conclusion 
In this chapter, we present an electrochemical imaging platform, which consists of an 
electrochemical sensor and FPGA-based data acquisition system, capable of recording a 32 × 32 
pixel array of sensors at 40,000 frames per second, one of the fastest reported to date. The presented 
electrochemical detector, an integration-capacitor-based TIA with an integrated electrode, is used 
throughout a 32 × 32 array to enable large-scale electrochemical recordings. To prepare the device 
for electrochemical experiments, post-CMOS processing is used to integrate a platinum MEA onto 
the CMOS chip and the device is prepared for single-cell applications by the integration of 15 μm 
× 15 μm SU-8 wells. To enable the fast 40 kHz frame rate, an FPGA-based data acquisition system 
is designed to operate the electrochemical sensor and digitize the 32 parallel outputs of the CMOS 
chip. The device is used to successfully image the diffusion of dopamine and hydrogen peroxide 
over the 32 × 32 pixel array of sensors at a frame rate of 40,000 frames per second. The presented 
system provides significant benefits for studies that require high-throughput and high 
spatiotemporal resolution, such as high-throughput single-cell amperometry to study vesicle 
secretion, mechanisms of neurological diseases, and the dynamics of neurotransmitter release. 
  
74 
CHAPTER 5:  SINGLE-CELL RECORDING FROM HUMAN NEUROBLASTOMA 
CELLS USING 1024-CH CMOS BIOELECTRONICS 
5.1 Chapter Notes 
In this chapter, we report the measurement and characterization of neurotransmitter 
secretion from human neuroblastoma cells (SH-SY5Y) using the 1024 channel CMOS 
neurochemical microelectrode array. Human neuroblastoma cells, SH-SY5Y, are often used as a 
neuronal model to study Parkinson’s disease and dopamine release in the substantia nigra, a 
midbrain region that plays an important role in motor control. Secretions from 76 cells are 
simultaneously recorded by loading the CMOS device with SH-SY5Y cells. In the presented 42-
second measurement, a total of 7147 single vesicle release events are monitored. The study shows 
the CMOS device’s capability of recording vesicle secretion at a single-cell level, with 1024 
parallel channels, to provide detailed information on the dynamics of dopamine release at a single-
vesicle resolution. The work described in this chapter was completed with Geoffrey Mulberry, 
Jonhoi Smith, Manfred Lindau, Bradley A. Minch, Kiminobu Sugaya, and Brian N. Kim *. 
5.2 Introduction 
Neurotransmitter release is modulated by molecular manipulations related to neurological 
diseases [1] and drug treatments [2]. For example, Parkinson’s disease can considerably reduce 
the quantity of dopamine release [3] while the drug L-Dopa can increase the amount of secretion 
[2]. The release of neurotransmitters occurs in quantal packets when vesicles fuse with the cell 
membrane. By studying the secretion from individual vesicles, we gain rich information regarding 
 
* In this chapter, we use material published in IEEE Transactions on Biomedical Circuits and Systems 2018, [24] 
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the dynamics of membrane fusion [4], obtain insight into the mechanisms of neurological diseases 
at the molecular level [5], and learn both the desirable and undesirable side effects of drug 
treatments [6], [7]. Neurosecretory vesicles are small, commonly less than 100 nm in diameter. 
Release from such a vesicle is a fast process which occurs on a time scale of milliseconds or less 
and is thus difficult to observe using microscopy. Thus, an electrochemical method (amperometry) 
is widely used to monitor neurotransmitter release with high temporal resolution by oxidizing 
neurotransmitters at an electrode [4]. Oxidation is the process of molecules, such as the 
neurotransmitters dopamine, epinephrine, norepinephrine, and serotonin, releasing electrons into 
the electrode, generating picoampere currents that can be measured with high-quality low-noise 
amplifiers. Cyclic voltammetry is also an electrochemical method which is capable of measuring 
neurotransmitter levels but suffers from a lower temporal resolution compared to amperometry 
and is adequate for detecting the neurotransmitter level in a slow dynamic system. However, 
amperometric measurements conducted at the single-cell level and single-vesicle level are 
traditionally a low-throughput method where each cell is measured individually with a 
microelectrode under microscopic observation, which makes the technology costly and time-
consuming to acquire sufficient data to derive statistically significant conclusions.  
The limitations of single-cell amperometry can be overcome by using a scalable CMOS 
device in which the electrodes are each directly integrated with a dedicated amplifier. Several 
CMOS-based monolithic biosensors have been proposed using this concept of monolithic 
integration [34]–[39] to perform various types of electrophysiology with enhanced spatiotemporal 
resolution. A device that was proposed for the application of DNA sequencing integrated a solid-
state nanopore onto a CMOS chip and achieved enhanced temporal resolution as well as low noise 
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performance with a sampling rate of up to 20 MHz [35], [70]. For the purpose of measuring action 
potentials from a neuron with a high spatiotemporal resolution, a multifunctional CMOS chip with 
an array of 59,760 on-chip electrodes can provide a high channel count of up to 2048 electrodes 
for simultaneous recording [36], [42]. The multifunctional CMOS chip featured 28 amplifiers for 
neurotransmitter detection using cyclic voltammetry with the 100s of pARMS noise level. Using an 
array of 11,011 electrodes, action potentials from axons in a neuronal network were measured with 
high spatiotemporal resolution [37], [43]. Impedance spectroscopy with a high spatial resolution 
and low-noise was performed with an array of 59,760 electrodes integrated onto a multifunctional 
CMOS chip [44]. To study bursting events from neurons in a neuronal network, a device providing 
high spatial resolution with an array of 4096 electrodes was proposed [45]. Another proposed 
system contains 1024 pixels to provide a low-noise multifunctional CMOS device with enhanced 
spatiotemporal resolution for extracellular potential measurement, optical cell detection, current 
stimulation, and cellular impedance measuring [39]. A low-noise device with an integrated on-
chip electrode array was developed for the purpose of parallel recording of neurotransmitter release 
with a channel count of 100, providing high-throughput amperometric measurements [34]. This 
monolithic integration of an on-chip electrode array onto a CMOS device has demonstrated the 
feasibility of recording neurotransmitter release with high-throughput and a fine spatiotemporal 
resolution [34]. However, the fabricated array did not provide any provision for isolating the 
electrodes, thus allowing multiple cells to sit atop an electrode, and secretions from adjacent cells 
can influence readings from the electrode of interest. To address this issue, microwells as described 
by [27] were incorporated into a 100-electrode amperometry chip [64]. In this chapter, we will 
present a monolithically integrated CMOS-based electrochemical sensor array with 1024  
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Figure 5.1: Schematic view of the half-shared OPA and TIA designs. One half-OPA is shared 
among four TIAs. In a TIA, the current induced by the oxidation of neurotransmitters (IelecN) is 
added to an offset current (Ioffset). The currents are integrated on an integration capacitor (CintN) 
and read out periodically (VoutN). 2018 © IEEE 
electrode-amplifier pairs operating at a frame rate of 10,000 per second, one of the fastest reported 
to date. Through the use of SU-8 in post-CMOS processing, structures are created to permit only 
a single-cell to rest on an electrode. Thus, the monolithic device is able to record neurotransmitter 
release throughout the array at a single-cell level and permit the resolution of single vesicle release 
events. The ability to offer a high density of single-cell measurements in a matter of minutes with 
the presented device offers significant benefit in regard to the study of the dynamics of 
neurotransmitters and the underlying mechanisms of vesicle secretion. To demonstrate the 
capabilities of this device, we recorded vesicle secretion from SH-SY5Y cells, a type of 
neuroblastoma cell that is used as an in vitro model for dopaminergic neurons. SH-SY5Y cells are 
often chosen for Parkinson’s disease studies because of their human origin and similar 
catecholaminergic neuronal properties to dopaminergic neurons of the midbrain [81], [82]. 
In Section 5.3, we discuss the design and characterization of CMOS devices with 1024 
transimpedance amplifiers (TIAs). In Section 5.4, we describe post-CMOS processing for 
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integrating an on-chip electrode array. In Section 5.5, we discuss on-chip recordings of SH-
SY5Y’s dopamine releases using the monolithic CMOS device. In Section 5.6, we analyze the 
measurements of neurotransmitter release.  
5.3 Design of 1024-ch Transimpedance Amplifier Array 
 In this section, we describe the design of our CMOS device comprising a 1024-ch TIA 
array integrated with an on-chip array of 1024 electrodes. The resulting high-density electrode 
array is capable of measuring picoampere currents. 
5.3.1 Half-Shared Operational Amplifier Design 
Designing a small-sized TIA is a requirement to enable the integration of an array of 1024 
amplifiers into a single silicon die. To use the silicon area most effectively, we adapted the half-
shared operational amplifier (OPA) design of [49]. In this design, the non-inverting input is shared 
by several inverting inputs. The half-shared design achieves a significant reduction of cell area by 
almost a factor of two and reduces the power consumption by nearly half. The disadvantage of the 
half-shared design is the lack of individual control of the non-inverting input voltages. However, 
in many high-throughput applications including amperometry, individual control of the non-
inverting inputs is not necessary [34], thus making the half-shared design advantageous. The half-
shared design and TIA design is depicted in Fig. 5.1. The OPA uses a simple five-transistor design 
to minimize the area and power consumption. The current mirror, formed by M2 and M4N, closely 
matches the current level in all branches of sharing OPAs. The non-inverting input transistor, M1, 
is in the half-OPA and the inverting input transistor, M3N, is in the individual TIA. Negative 
feedback through M6N regulates the voltage at electrodeN to be the same as the non-inverting 
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input voltage (Vref). The TIA uses a two-stage amplifier, thus the phase margin needs to be 
considered. The open-loop configuration without feedback is studied with M3N gate as the input 
and M6N source as the output. Two poles are from the M3N drain and M6N source. The dominant 
pole is introduced from the capacitance at the electrode and the 2nd pole can be close to the 
dominant pole because M3N is operating in moderate to weak inversion. Thus, a compensation 
capacitor (CcompN), a 20-fF polysilicon-insulator-polysilicon (PiP) capacitor, is used to increase the 
phase margin of the TIA by producing a zero (gm3N/CcompN) which closely matches the frequency 
of 2nd pole from M3N. The current from the electrode (IelecN) is integrated onto the integration 
capacitor (CintN), which causes the voltage of CintN to drop (ΔV). This voltage drop is readout 
periodically with a cycle interval (Δt) from each TIA. The cycle interval is determined by the 
desired sampling rate. For example, if a cycle interval of 100 µs is used, the resulting sampling 
rate of the TIA is 10 kS/s. During the readout, CintN is reset through M7N transistor to re-initiate 
the next cycle of integration. The dimensions of each transistor in the TIA design are listed in 
Table 5-1. CintN represents the total capacitance at the integrating node, including a passive PiP 
capacitor component and parasitic capacitors added by nearby transistors (M6N and M7N). The 
TIA includes two interchangeable CintNs, whose estimated capacitances are 116 fF and 13 fF. The 
transimpedance gain of the TIA is determined by Δt and CintN. The measured transimpedance gain 
of every 1024 amplifiers is 0.86 ± 0.03 mV/pA (standard deviation, SD) and 7.72 ± 0.99 (SD) 
mV/pA, for 116 fF and 13 fF, respectively. A larger deviation in gain is observed when using the 
13-fF CintN compared to using the 116-fF CintN. This is because the small CintN is largely made of 
parasitic capacitance at the integration node which is inconsistent across the array. The integrating 
capacitor is incapable of integrating negative current, thus only offering unipolar measurements. 
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To enable bipolar measurements, an offset current (Ioffset) is applied in the TIA using M5N. Ioffset 
is superimposed on IelecN to generate IintN, and when the electrode current drops below zero, IintN 
reduces below Ioffset. IelecN can drop as low as -Ioffset and still sustain a positive current through 
M6N. If IelecN falls below -Ioffset, the negative feedback will be disabled, effectively turning off the 
TIA. Thus, the TIA is capable of bipolar measurement with a dynamic range of -Ioffset to + 
(CintN×(VDD-Vref)/Δt) – Ioffset. The TIA’s dynamic range is -500 pA – 2516 pA with CintNs of 116 
fF, Δt of 100 µs, Ioffset of 500 pA, and Vref of 0.7 V. 
5.3.2 Bandwidth and Noise Characteristics 
The TIA is characterized by injecting known AC and DC currents into the electrode node. 
The TIA’s frequency response is measured by applying sinusoidal voltage (AC amplitude: 200 µV 
– 2 mV) through a 1-M resistor into the amplifier, for a range of frequencies extending beyond 
the Nyquist frequency. This input generates a sinusoidal current of 200 pA – 2 nA that can be 
measured using the TIA. We chose a 1-M resistor because of a possible zero interfering with the 
frequency-response measurement. An introduction of the zero by the input resistor (and its parallel 
parasitic capacitor) in the low-frequency range can cause a larger input current which results in a 
misinterpretation of the frequency response. With an approximate parasitic capacitance of 500-fF 
across the resistor, the zero of the input resistor and the parasitic capacitor is expected to be at 318 
kHz, which is beyond the frequencies of interest. As expected, the frequency response of the TIA, 
as a result of periodic sampling of the integration capacitor, has the characteristics of the sinc 
function (Fig. 5.2). When examining the characteristics of the TIA in the frequency domain, two 
bias conditions are tested: Ibias of 517 nA and 55.2 nA. The dominant pole of a sinc filter at a  
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Figure 5.2: The frequency response of the half-OPA-based TIA. 2018 © IEEE 
sampling rate of 10 kS/s is expected to be ~ 4.4 kHz, thus the influence of the biasing level is 
limited while the sinc’s dominant pole is lower than the bandwidth of the OPA. The frequency 
response follows the characteristic of a sinc filter with a -3 dB point of ~4.4 kHz. The frequency 
response beyond the -3 dB point still influences the sampling bandwidth, thus aliasing, however, 
the frequency response sharply drops with the sinc filter. Peaks of side lobes follow an 
approximately -20 dB/dec slope up until 5th sidelobe, which is equivalent to a single-pole anti-
aliasing filter. Because the sinc filter has nulls at every integer of the sampling frequency (10 kS/s), 
the aliasing noise is smaller compared to a single-pole anti-aliasing filter. When the electrolytic 
solution is placed on the electrode, the double-layer capacitance, which can be in the order of tens 
of pF, is likely to influence the performance of the TIA. With an electrolytic solution covering the 
array, an average noise of 6.16 pARMS is measured with the corner frequency of the capacitive 
noise ranging from 60 to 200 Hz. The test conditions are a bias level of 55.2 nA and an Ioffset of 
100 pA. The presented bandwidth measurement (Fig. 5.2) is performed by using a bus that runs 
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across the entire array, ExConE. When ExConE is connected to the TIA, 25.81 pF of input 
capacitance is measured at the electrode node. This capacitance is only present to the electrode 
node during the bandwidth measurement and is removed by an internal switch controlled by 
embedded SRAMs (explained in Section 5.3.3). Therefore, the bandwidth in the presence of the 
electrode-electrolyte interface is expected to be comparable to the measured bandwidth.  
Because of the integrating capacitor’s intrinsic characteristic, noise introduced from 
aliasing is minimal. This built-in low-pass filter eliminates the need for an anti-aliasing filter in 
the readout circuitry, resulting in a smaller design area. Under these test conditions, each TIA 
consumes 182 nW to maintain the full bandwidth and performance. Overall, the average noise 
level of all 1024 amplifiers is 421.4 ± 1.1 (SD) fARMS at 10 kS/s using the 13-fF CintN. Because 
shot noise is expected to be 400 fARMS with the 100 pA DC current, the contribution of the 
amplifier can be calculated to 132.6 fARMS. For Ioffset levels of 500 pA and 1000 pA, the measured 
noise levels are 1.496 ± 0.012 (SD) pARMS and 1.769 ± 0.028 (SD) pARMS. The noise levels of the 
TIAs are measured at the 55.2-nA bias level. One selected TIA exhibits noise levels of 415 fARMS, 
622 fARMS, and 1083 fARMS, at sampling rates of 10 kS/s, 20 kS/s, and 30 kS/s, respectively at the 
55.2-nA bias level with Ioffset set at 100 pA (Fig. 5.3a). Compared to a high-quality 
electrophysiology amplifier, the Axopatch 200B with a resistor-feedback headstage and 10 mV/pA 
gain with a 100 pA input current, the measured noise spectral density of the TIA demonstrates 
comparable noise performance (~ 4 × 10-5 pA2/Hz) (Fig. 5.3). The noise simulation based on the 
technology-specific parameters are also presented (Fig. 5.3c). Because the noise analysis on a non-
stationary circuit is impractical, a load resistor is added into the integrating node VoutN in Fig. 5.1 
to produce a stationary circuit. The simulated noise is then multiplied to a sinc function to emulate  
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Figure 5.3: Performance of the TIA array. (a) The noise levels of the amplifier at 3 different sample 
rates. (b) Bipolar current measurement using the TIA. (c) The noise spectral density of the 
amplifier when Ioffset is set to 100pA, 500pA, and when an electrolytic solution covers the array. 
2018 © IEEE 
the filtering effect from the integrating capacitor. For the electrolytic solution simulation, we added 
a 25-pF input capacitor to represent the electrode-electrolytic interface capacitance. The flicker 
noise matches closely between the measurement and the simulation result. Typically, the flicker 
noise corner can be below 10 Hz when the input current level is deep in weak inversion [83], which 
agrees with the measured noise spectral density. However, a mismatch in noise level is observed. 
This may be due to the poor matching of the design parameters in the deep weak-inversion. 
Designing the TIA with small-sized transistors can result in large mismatches between identical 
TIAs. This is due to the manufacturing imperfection that mainly influences effective width (W)  
and length (L) of fabricated transistors [84]. The OPA determines the bandwidth and VelecN, and 
thus transistors in the OPA need large W and L to minimize mismatch. By adapting the half-shared 
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OPA, investment in a large area for W and L is achievable as the inverting-half of an OPA requires 
only two transistors, M3N and M4N. The size selected for M3N and M4N is 10 µm × 10 µm (Table 
5-1). The input-referred output is measured throughout the array, resulting in a measured variation 
of 1.26 mVRMS. Ioffset is also subject to mismatch due to process variation. However, the mismatch 
in Ioffset across the array only affects the dynamic range by several pA which has negligible effect 
during the electrochemical recordings.  
Table 5-1: Dimensions of transistors in the TIA design 2018 © IEEE 
 M1 M2 M3N M4N M5N M6N M7N 
Width 10 μm 10 μm 10 μm 10 μm 5 μm 1.2 μm 0.8 μm 
Length 10 μm 10 μm 10 μm 10 μm 5 μm 1.2 μm 0.4 μm 
        
The crosstalk between the sharing OPAs has been considered. As discussed by a previous 
publication [49], the response of each inverting-half of OPA is only a function of transconductance 
(M3N) and output impedance (M4N). Thus, as long as the sharing node (M3Nsource) is kept constant 
with a constant non-inverting input, the crosstalk should be minimal. To confirm this, a 100 Hz 
current with 400 pA pk-to-pk is injected into an OPA while recordings are taken from three OPAs 
which share the inverting-half. The power loss between the original injected current and crosstalk 
measured from sharing OPAs is quantified. A heavy attenuation of -38.7 dB ± 3.4 dB (standard 
deviation) is observed. The small crosstalk may be due to the limitation of the recording setup 
rather than actual crosstalk through the sharing structure. The 100 Hz current is injected through a 
bus which runs across the entire array, which is only enabled during the electrical testing. 
5.3.3 Integration of 1024-ch Amplifier Array 
Fig. 5.4 shows a CMOS device containing an array of 32 × 32 amplifiers and electrodes 
fabricated in a standard 0.35-µm 4-metal 2-poly CMOS process. In the presented design, four TIAs  
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Figure 5.4: Photographs and architecture of the CMOS die and amplifier array. (a) The array has 
1024 amplifiers and 1024 on-chip electrodes. The 32-to-1 multiplexer combines outputs by time-
division multiplexing to condense the data. Row and column decoders allow for fully-addressable 
writing of embedded SRAMs in the array. (b) Each TIA has low-gain (using LoG), phase margin 
(using Phs) options. Also, SRAM can be programmed to connect the ExConE node to the electrode 
node for testing. (c) The layout of one TIA is 30 µm × 30 µm. (d) The microphotograph of the TIA 
is showing PiP capacitors and glass opening. 2018 © IEEE 
share one non-inverting-half OPA. Each TIA occupies a 30 × 30 μm2 area and includes a 1-bit 
SRAM. Thus, the array has a total of 1024 1-bit SRAMs. Using the column and row decoders, the 
embedded SRAM in each TIA is fully-addressable providing the capability to reconfigure the 
amplifier for unity gain, and/or enable testing circuitry. Also, global switches can be used to change 
the transimpedance gain and enable/disable the phase compensation capacitor. 
To operate the array, two clock signals are applied to the timing circuitry and clock signals 
are generated to achieve time-division multiplexing, correlated double sampling (CDS), and 
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resetting of the integration capacitors (Fig. 5.5). The generated clocks provide the means of 
condensing the output of the array of 1024 sensors to 32 parallel outputs, one output per column, 
output(M), through time-division multiplexing. Time-division multiplexing will sequentially 
stagger the integration period of each row, reading out the integrated current of one TIA, ΔVN, 
while the other amplifiers in the column continue to integrate their respective inputs, as previously 
described [34]. The array with all the peripheral circuits is compacted and only occupied ~ 1.5 mm  
× 1.5 mm. In this 5 mm × 5 mm silicon chip, there are also electrostatic discharge (ESD) circuits 
and unused testing circuits which are not visualized in the microphotograph in Fig. 5.4. 
Because the CMOS chip relies on external ADCs for digitization, source-follower-based 
output buffers are designed to drive the capacitive load from the output line, pad, and ADC input 
capacitance. The overall power consumption of the chip is 12.5 mW.  
 
Figure 5.5: The block diagram of time-division multiplexing and timing diagram. Each gold 
electrode (yellow box) is connected to its respective TIA which is physically embedded directly 
underneath. Each row of TIA has a dedicated reset, Reset(N). The integrated voltage, ΔVN, is 
generated from each TIA after each reset. Each Reset(N) is synchronized with RowSel(N) which 
samples the TIA output before and after each reset, thus enabling correlated double sampling. The 
integration periods of each TIA in every row are staggered in time to allow the time-division 
multiplexing without deadtime in integration. After multiplexing, output(M) includes ΔVN of all 
the rows. 2018 © IEEE 
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5.4 Post-CMOS Processing 
CMOS chips fabricated from foundries commonly have aluminum-copper (Al/Cu) for the 
top metal layer. The aluminum is highly reactive with electrolytic solutions, making the 
unprocessed devices intrinsically inadequate for biosensing. This reactive material not only causes 
large offsets in electrochemical recordings, thus introducing a high level of shot noise, but the chip 
can also be damaged due to water leakage. To resolve this issue, post-CMOS processing can be 
used to integrate polarizable electrode materials, such as gold or platinum, on top of the topmost 
metal layer. These materials have low reactivity, making them suitable for biological recording. \ 
5.4.1 On-chip Gold Electrode Array 
The CMOS dies are first processed using photolithography to integrate the gold electrode 
array onto the surface of the chip through a lift-off process. Each die (5 mm × 5 mm) is initially 
attached to a coverslip (25 mm × 25 mm) to reduce the complications of handling the small CMOS 
chips through the standard cleanroom process. Before the chips are spin coated with photoresist, 
they are cleaned using acetone, isopropanol, and deionized (DI) water. A negative photoresist, 
NR9-1500PY, is spin coated onto the surface of the chip, exposed, and developed to create the 
patterns for the electrodes, leaving a sacrificial layer of photoresist on the surface where metal 
deposition is undesirable. The electrodes are created by first depositing 15 nm of titanium and then 
150 nm of gold on the surface of the chips through sputtering (AJA Six-Gun Sputtering System, 
AJA International Inc., N Scituate, MA). The purpose of the deposited titanium is to provide 




Figure 5.6: Post-CMOS processing for on-chip integration of electrodes and SU-8 wells. Initially, 
the CMOS die has Al/Cu as the top metal. Gold layer is patterned using lift-off process which is 
followed by the fabrication of SU-8 wells. The SU-8 wells are used to trap single cells. 2018 © 
IEEE 
the sacrificial layer of photoresist, lift-off is performed by rinsing the chip with acetone. After 
removal of the sacrificial layer, the electrodes are patterned as intended (Fig. 5.6). 
5.4.2 SU-8 Traps for Single-Cell Analysis 
After lift-off has been completed, the chips are cleaned again using acetone, isopropanol, 
and DI water. With the array of gold electrodes integrated onto the surface of the chip, further 
photolithography processing is performed using SU-8 3010, a biocompatible epoxy-based 
photoresist. The SU-8 photoresist is used to provide isolation between each electrode in the array 
and to create well structures that can trap a single cell on top of an electrode [27], [64], as shown 
in Fig. 5.6. The estimated thickness of SU-8 traps is 20 – 30 µm. To achieve true single-cell 
measurements, the SU-8 is necessary to not only prevent multiple cells from populating a single 
electrode, but to also prevent the influence of adjacent cells and electrodes.  
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5.4.3 Packaging 
After the array of electrodes and SU-8 traps are integrated onto the surface of a chip, it is 
bonded to a PCB die holder using a silver-filled epoxy (Fig. 5.7a). Once the epoxy has cured, the 
chip is wire-bonded to provide an interface to the inputs and outputs of the circuitry on the chip. 
To protect the easily broken wire bonds when handling the PCB and from liquids during 
experiments, a plastic well is manufactured to cover and protect the bonds and pads exposed on 
the chip. The well is designed to accommodate 2 mL of liquid, 3D-printed using ABS plastic, and 
coated with a layer of polydimethylsiloxane (PDMS) for waterproofing and biocompatibility. The 
coated well is bonded to the custom PCB and the surface of the CMOS chip using additional 
PDMS. As shown in Fig. 5.7b, the well conceals the wire bonds, provides an opening for access 
to the surface of the CMOS chip, and protects external electronics from liquids used during 
experiments. To prepare the CMOS chip for SH-SY5Y cell measurements, the packaged devices 
is cleaned using a plasma cleaner (PDC-32G, Harrick Plasma, Ithaca, NY). This is necessary as 
there is a remaining thin film of SU-8 over some of the electrodes in the array after the resist is  
 
Figure 5.7: The recording setup of the CMOS chip. (a) Biocompatible packaging of the CMOS 
chip by using PDMS-coated 3D-printed ABS well. (b) The photograph of the electrode array 
opening. (c) The custom-design PCBs for biasing and data acquisition using USB 3.0. 2018 © 
IEEE 
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developed. After plasma cleaning, 1 mL of water is added to the surface of the chip, and the device 
is placed into a vacuum chamber. By vacuuming the chip with liquid on the surface, bubbles that 
are captured in the SU-8 traps will be eliminated. After eliminating the bubbles in the SU-8 traps, 
the surface of the CMOS will continue to be covered with liquid to prevent air from being captured 
in the SU-8 single-cell traps. 
5.5 SH-SY5Y Cell Measurements 
5.5.1 Recording Setup 
The setup for SH-SY5Y cell recordings is shown in Fig. 5.7c. It consists of custom PCBs 
that hold a socket for the packaged chip, supply power and biasing to the chip, and convert and 
transmit analog data collected from the chip to a computer through a USB interface. The PCB die 
holder has pin headers to allow access to the inputs and outputs of the chip for testing and 
operation, as well as setting the current biasing for the TIAs in the array and the output buffers 
using resistors. The smaller PCB that connects to the foot of the PCB holding the socket generates 
the voltages needed for the chip to operate and the baseline current used for the TIAs. When 
operating the chip, Vref is set to 0.7 V and Ioffset is set to 500 pA.  
The USB data acquisition system consists of a custom-designed PCB that has a 
microcontroller (Atmel SAM E70), 32 ADCs with 16-bit resolution (LTC2323-16), and a USB 
3.0 controller (Cypress FX3). The Atmel chip functions as the control center for the acquisition 
system. All of the clocks required for the data acquisition system and the CMOS chip, are 
generated by this Atmel chip. The clocks generated for the CMOS chip are setup to achieve a 
sampling rate of 10 kHz for each amplifier and a multiplexed output rate of 320 kHz. The Atmel 
chip also provides the digital signals for the column and row decoders to program the SRAMs in 
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the array as well as the reference voltage for the amplifiers through an embedded DAC. The 32 
ADCs convert the 32 parallel, time-multiplexed, signals from the CMOS chip into their binary 
representations at a rate of 1.3 MHz. The binary data from these ADCs are delivered directly to 
the USB 3.0 controller. The USB controller accumulates the data from the ADCs in its embedded 
memory and then transfers the data to a connected computer in packets at a rate of 106 MB/s.  
5.5.2 Single-Cell Amperometry 
SH-SY5Y neuroblastoma cells (ATCC# CRL-2266) are cultured in T-75 flask with 20 ml 
of growth media, which consists of a 1:1 ratio of MEM with L-Glutamate (Invitrogen) and F12 
media (Invitrogen), 10% fetal bovine serum (FBS, Gibco) and 1% Antibiotic/antimycotic (Gibco). 
The cells are cultured in a 5% CO2 incubator at 37˚C. The media is changed every 3 days. These 
cells mostly grow as adherent cells under these conditions. Cells are passaged when the culture 
becomes 80% confluent. To detach the cells, the growth media is removed, the cells washed with 
phosphate-buffered saline (PBS, pH7.4), and incubated with Trypsin-EDTA (Gibco, 0.25%) at 
37˚C for 5 minutes, until most of the cells are detached from the flask. Trypsin is deactivated by 
the addition of FBS. The cells are washed twice with PBS by centrifugation at 1500 rpm for 5 
minutes. The cells are then immediately used for the experiments or plated in a new T-75 flask for 
further expansion in the culture. 
For the recording of neurotransmitter releases from SH-SY5Y cells, the 1 mL of water that 
is on the chip (refer to Section 5.4.3) is replaced with 1 mL of suspended SH-SY5Y cells in culture 
media. With the cells floating on the surface of the packaged chip, it is placed into an incubator at 
a temperature of 37˚ C and 5% CO2 for one hour to provide time for the cells to be captured in the 
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SU-8 traps and settle onto the bottom surface. Settled cells are randomly distributed on the CMOS 
chip. Some cells adhere to the SU-8 surface and some cells fall into the SU-8 traps. Once the cells 
are trapped and adhered in the SU-8, the 1 mL of culture media is exchanged with 1 mL of 
recording buffer. The recording buffer contains the following concentrations at a pH level of 7.3 
and an osmolality of 300 mmol/kg: 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM CaCl2, and 
10 mM HEPES/NaOH. At this point, the chip with cells is ready for recording and is placed into 
the socket (Fig. 5.7c). An Ag|AgCl reference electrode connected to ground is placed in the 
recording buffer and then the power and clock signals are applied to the chip. To stimulate the 
cells, 1 mL of a high KCl stimulation buffer is added to the recording buffer. The stimulation 
buffer has the same pH level and osmolality of 7.3 and 300 mmol/kg, respectively, with the 
following concentrations: 140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 10 mM CaCl2, and 10 mM 
HEPES/NaOH. The anticipated KCl concentrations after adding the stimulation buffer is 72.5 mM, 
which is known to cause depolarization of the cell membrane and stimulate vesicle secretions [85].  
5.5.3 1024-ch Parallel Recordings of Vesicle Releases Using CMOS Chip  
 The diameter of a suspended SH-SY5Y cell is ~12 µm, which is marginally smaller than 
the 15 µm × 15 µm SU-8 single-cell traps (Fig. 5.8). Many individual SH-SY5Y cells trapped in 
SU-8 wells are observed (Fig. 5.8b), allowing single-cell amperometry from the respective 
electrodes. Multicellular clumps that are also present failed to fit into the SU-8 traps because the 
SU-8 trap is only large enough for a single cell (Fig. 5.8b). For this experiment, of the 1024 SU-8 
traps, roughly ~10% of the electrodes in the array are covered by a single cell. The CMOS device 
successfully measured amperometric spikes simultaneously from 76 electrodes out of 1024  
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Figure 5.8: (a) Microphotograph of SH-SY5Y cells on the CMOS device. (b) Differential 
interference contract (DIC) image of SH-SY5Y cells on the CMOS device. Single SH-SY5Y cells 
are trapped in SU-8 traps. The traps allow only single cells to fall in to make contact with the 
electrode. The image has been processed by adjusting the contrast. 2018 © IEEE 
electrodes in a single set of measurements (Fig. 5.9a). This is identified by manually monitoring 
the amperometric recordings from individual electrode-amplifier. Each spike corresponds to 
dopamine release from a single vesicle. The recorded data are read and demultiplexed using a 
custom-written MATLAB code. The amperometric data are then imported to Igor Pro 7 and 
analyzed using Quanta Analysis v8.20 [10]. In the representative measurements shown in Fig. 
5.9b, vesicle secretions as small as 9.6 pA and as large as 1487 pA are observed, with an average 




Figure 5.9: (a) Parallel recordings of 76 single-cell vesicle secretions. (b) A representative 
recording shows individual spikes corresponding to single vesicle release of neurotransmitters. 
2018 © IEEE 
particular single cell are detected. The events from this cell exhibited an average half-width of 1.26 
ms. To determine the number of released neurotransmitters, the quantal size can be found by  
integrating the current measured from each spike. For this cell the average quantal size is 0.288 
pC, corresponding to the release of ~900,000 dopamine molecules per vesicle. 
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5.6 Statistical Analysis of Amperometric Spikes 
About 7147 vesicle secretions are detected from all 76 measurements. The characteristics 
of all measured spikes, including the half-width (t1/2), maximum current (Imax), and amount of 
dopamine, are analyzed (Fig. 5.10). The average half-width is 1.63 ms with a standard deviation 
of 1.00 ms. With the 4.4-kHz bandwidth of the CMOS device, spikes with above 1-ms half-width 
can be measured reliably, however, faster spikes from rat ventral midbrain dopamine neurons, with 
100 – 600 µs half-width, may be difficult to resolve using this CMOS device [8]. This observation 
is consistent with measurements from other neuroblastoma cell lines [5] and neurons [86], but the 
half-width from SH-SY5Y cells is significantly faster than that obtained for endocrine cells, such 
as PC-12 and bovine chromaffin cells [7], [67], [87]. The number of events varied from zero to 
419 per cell, with 94 events per cell being the average. For the 76-cell measurements, the average 
amount of dopamine release from a single vesicle is 1.86 attomole, corresponding to ~1.12 × 106 
molecules per vesicle. The number of dopamine per vesicle in human blastoma SH-SY5Y cells is  
about 100 times larger than that of rat ventral midbrain neurons [8], and is about 4 times less than 
that of bovine chromaffin cells [17]. 
5.7 Conclusion 
In this chapter, we present a 1024-channel monolithic CMOS bioelectronics device, 
enabling high-throughput recordings of vesicle secretion from SH-SY5Y cells. Each electrode in 
the array, 15 µm × 15 µm in size, has a dedicated TIA that has a small footprint of 30 × 30 μm2 
and fully addressable SRAMs to configure the sensors individually. The 1024-ch sensor array 
operates with a frame rate of 10,000 per second. We discussed in detail the device packaging, a  
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Figure 5.10: The characteristics of vesicle secretions in human neuroblastoma cells, including half-
width, maximum current, the amount of dopamine released, and number of vesicle release per cell. 
2018 © IEEE 
completely in-house process that protects the wire bonds as well as pads, provides a reservoir to 
contain solutions, provides access to the electrode array on the surface of the device, and protects 
external electronics interfacing with the device. Monolithic integration of the gold electrodes and 
SU-8 single-cell traps to the surface of the CMOS bioelectronics is demonstrated to permit on-
chip high-throughput single-cell amperometry. To demonstrate the feasibility of the device, SH-
SY5Y cells are placed onto the sensor array to measure dopamine released from the cells after 
stimulation. Single-cell recordings of 76 cells and 7147 vesicle release events are captured in 
several minutes. This would have taken significantly longer, on the scale of months, to acquire 
using traditional instrumentations. The fine temporal resolution of the TIAs are able to capture the 
neurotransmitter secretions of the SH-SY5Y cells, which exhibited a fast half-width average of 
1.63 ms. The presented system design enables the high-throughput study of vesicle secretion at the  
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Table 5-2: Comparison to State-of-the-Art CMOS Bioelectronics 2018 © IEEE 
Reference [8] [12] [13] [15] This Work 
Technology Node 0.5 μm 0.18 μm 0.13 μm 0.18 μm 0.35 μm 
Die Size 3 mm × 3 mm 5 mm × 2.65 mm 3 mm × 2 mm 
12 mm × 8.9 
mm 
5 mm × 5 mm 
Number of 
Electrodes 
100 200 1024 59760 1024 
Electrode Size 15 μm × 15 μm 10 μm × 10 μm 28 μm × 28 μm 3 μm × 7.5 μm 15 μm × 15 μm 
Electrode Material Platinum 
CNT Coated Gold (Current 
channels), Gold (Voltage 
Channels) 
























- 200 4 2048 - 
Noise performance 
(Voltage) 
- 4.07 μVRMS at 100 kHz 13 μVRMS 4.4 μVRMS - 
Bandwidth 
(Voltage) 




- 200 kS/s - 640 kS/s - 
ADC 16-bit off-chip 10-bit on-chip 16-bit off-chip 10-bit on-chip 16-bit off-chip 
Total Power - 3.21 mW - 86 mW 12.5 mW 
      
Single-cell level through monolithic integration of an array of 1024 electrode-amplifier pairs with 
SU-8 single-cell traps, a biocompatible packaging process, and digital circuitry that enables 1024 
parallel recordings at a rate of 10 kS/s/ch. The presented system design marks a significant 
advancement in regard to the field of single-cell electrophysiology, which is hindered by the low 
throughput of traditional methods. A comparison of the presented system design to recent state-
of-the-art CMOS bioelectronics is presented in Table 5-2. The device is demonstrated to provide 
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improved benefit toward revealing the rich information regarding the dynamics of vesicle secretion 
and the underlying mechanisms of neurological diseases. For the study of neurological diseases 
and drug treatments that modulate neurotransmitter release, the presented device provides an 
excellent platform to obtain a significant amount of single-cell recordings to better arrive at 




CHAPTER 6:  QUANTIFYING NEUROTRANSMITTER SECRETION MODULATION 
USING HIGH-DENSITY CMOS NEUROCHEMICAL ELECTRODE ARRAY 
6.1 Chapter Notes 
In chapter 6, we apply the 1024 neurochemical microelectrode array to capture the 
modulation of neurotransmitter secretion to due pharmacological substances used for treating 
depression (desvenlafaxine) or Parkinson’s disease (L-Dopa and selegiline). To the best of my 
knowledge, the potential modulation to neurotransmitter secretion characteristics by 
desvenlafaxine and selegiline have not yet been studied. Additionally, the high-throughput 
screening capabilities exhibited in this chapter demonstrate that the novel technology developed 
in this dissertation can accelerate the study of neurodegenerative disorders and new 
pharmacological therapies that target the dynamics of neurotransmitter secretion. The work 
described in this chapter was completed with Brian N. Kim*.  
6.2 Introduction 
Chemical transmissions at synapses are an essential mechanism in neuronal networks, 
because they facilitate the propagation of information throughout the nervous system for body 
functions, memories, and emotions. These chemical transmissions relay information between 
neurons through the secretion of membrane-bound neurotransmitters, which exist in high 
concentrations within vesicles. Neurotransmitters are released in quantal events through a fusion 
pore, which are created when vesicles fuse with the plasma membrane during the exocytosis 
process. Quantal events are fast, typically occurring in milliseconds or less, and the quantal size is 
 
* In this chapter, we use material published in Nature Communications, 2021 [114]. 
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small, containing less than attomoles of neurotransmitter molecules per quantum (vesicle) [5], [8]. 
An electrochemical recording using amperometry can reveal rich details of individual quantal 
events, including the sub-millisecond dynamics of quantal secretion, quantal size (# of molecules 
per vesicle), frequency, as well as the kinetics of vesicle fusion [10]. In the amperometric setup an 
electric potential is held between two electrodes, a reference electrode and a working electrode. 
This setup allows electroactive molecules, such as dopamine, serotonin, epinephrine, and 
norepinephrine, to undergo either oxidation, the release of electrons from the molecule, or 
reduction, the acquisition of electrons to the molecule, and generates a current that is measurable. 
Amperometric recordings using carbon fiber electrodes (CFEs) have been pivotal in 
studying the fundamental mechanisms of vesicle fusion [6], [8], [11], [16], [17] over many 
decades. Amperometry using CFEs have also been crucial for studying the molecular effects of 
neurological diseases and pharmacological treatments that modulate the exocytosis process [2], 
[18], [21]. The phenomenon of incomplete exocytosis events allowing recycling of vesicles for 
rapid reuse is called ‘kiss-and-run’ and has been studied extensively as this secretion regulation 
provides insights into neuronal communications and potentially the mechanisms of neuronal 
plasticity [11]. The study of this phenomenon is enabled by amperometry because these events 
require an enhanced temporal resolution to study these millisecond scale kiss-and-run events at a 
single vesicle scale [8], [12]–[16]. A protein that has been studied is alpha-synuclein, which has 
been implicated in the pathogenesis of Parkinson’s disease (PD) and has been found to reduce the 
frequency of exocytotic events by inhibition of vesicle priming for fusion with the cellular 
membrane [18]. In addition to studying the vesicle-level effects of neurodegenerative diseases, 
amperometry is used to study or monitor biomarkers that can reveal signs of a neurological disease. 
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The high sensitivity and temporal resolution of amperometry has enabled in vivo animal study of 
monitoring the concentration of nitric oxide, which is linked to neuronal loss [22].  
Despite the significance of the studies conducted and the discoveries made using 
amperometry, the CFE technique is labor-intensive [88]–[94], time-consuming [59], [91], [95], 
[96], and can take from weeks to several months [26] to research the effects of neurological 
diseases or pharmacological treatments. In these studies, it is important that amperometry is 
performed at the single-cell level to account for heterogeneity in the characteristics of quantal 
release among the cell population [10], [25]. Therefore, to compare the kinetics of quantal release 
and the size of vesicle secretion with statistical significance, typically more than 30 independent 
cell measurements are collected for both the experimental and control groups to develop 
meaningful conclusions. The prohibitive features of single-cell amperometry have limited the wide 
application of this technology to survey (or screen) the molecular effects of pharmacological 
modulations and neurodegenerative pathologies associated with the synaptic neurotransmitter 
secretion process.  
To overcome the complications of traditional single-cell studies, scalable complementary 
metal-oxide-semiconductor (CMOS)-based biosensors are being developed with integrated on-
chip electrode arrays [24], [34]. Developed CMOS-based biosensors have demonstrated their 
parallel recording capabilities through the mapping of the concentration of ferricyanide across a 
16 × 16 electrode array [40], the diffusion of H2O2 in a 32 × 32 electrode array [32], and the flow 
injection of several analytes across a 128 × 128 electrode array [41]. Furthermore, these CMOS-
based bioelectronic systems have been developed and used for high-throughput recordings of 
neurotransmitter secretion from bovine chromaffin cells with a 10 × 10 electrode array [26], [34] 
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and from human neuroblastoma cells (SH-SY5Y) using a 32 × 32 electrode array [24]. Using the 
10 × 10 electrode array, the effects of the antidepressant drugs, bupropion and citalopram, on 
neurotransmitter secretion have been studied [26]. 
In this chapter, we discuss the development of a novel silicon-based electrode array, which 
integrates 1024 on-chip microelectrodes (Fig. 6.1a-b), and is capable of single-vesicle resolution 
recordings. The designed silicon-based electrode array is based on CMOS technology, which 
enables a large-scale integration of amplifiers and other electronic circuits. An on-chip 
microelectrode array is integrated directly on the surface of the designed CMOS chip using 
additional steps of fabrication, post-CMOS fabrication. The presented post-CMOS processing has 
been modified from a previous work [24] to improve the noise performance of each 
electrochemical sensor through the use of a silicon dioxide insulation layer that defines the 
effective area of the electrodes throughout the array, thus permitting the developed system to 
record the small amperometric signals from single vesicle secretions. With the low-noise 
amplifiers in the CMOS chip and the improved noise performance due to the new post-CMOS 
process, this work presents the first single-vesicle recordings from pheochromocytoma (PC-12) 
cells using monolithically integrated CMOS biosensors. The presented silicon-based 
bioelectronics system can capture a large pool of quantal events in the span of minutes, providing 
rapid results compared to the conventional amperometry technique that can take from weeks to 
months to amass a comparable dataset [26]. Using data collected from two experiments, the 
statistical analysis presented reveals the changes in the characteristics of vesicle-membrane fusion 
and neurotransmitter release between a control group and L-Dopa treated group of PC-12 cells. 
The presented device provides a platform that can be used to closely monitor any pharmaceutical 
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modifications to the synaptic transmission process by PD treatments, Alzheimer’s disease 
treatments, alpha-synuclein deposits, depression therapies, and other therapies for 
neurodegenerative disorders, at the single-vesicle level.  
6.3 High-density Silicon-Based Electrochemical Microelectrode Array for Quantal Analysis.  
The microelectrode array is designed with each electrochemical sensor having a dedicated 
amplifier that permits electrochemical detection as conceptually illustrated in Fig. 6.1a. The 
CMOS device is fabricated using a standard 4-metal 2-poly 0.35 µm CMOS process and contains 
an array of 32 × 32 electrodes with an integrated amplifier array [24] (Fig. 6.1c). To detect the 
presence of neurotransmitters at an electrode, the amplifier integrates the electrons released from 
the electroactive molecules onto a capacitor, which results in a current-dependent voltage output, 
Voxidation (Fig. 6.1a). After the integration cycle, the output voltage is sampled and the charge across 
the capacitor is reset by a switch to initiate the next cycle. For efficient readout of the entire 
electrode array, there are 32 multiplexers (Fig. 6.1c) that handle the readout of the 32 columns of 
electrodes using a time-division multiplexing scheme. The multiplexers select one amplifier in the 
column for readout, while the other 31 amplifiers are still in their integration phase and operates 
in a sequentially staggered readout pattern to minimize integration dead time and maximize their 
sensitivity.  
CMOS fabrication foundries typically use an aluminum-copper (Al/Cu) alloy for the top 
metal layer, which is inadequate for neurotransmitter detection as it is highly reactive to 
electrolytic solutions. This highly reactive metal alloy results in significant current offsets, thus 
increasing the shot noise of the amplifiers. To make the electrode array suitable for 
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neurotransmitter detection, platinum electrodes are integrated onto the chip to provide a 
polarizable electrode material (Fig. 6.1c-e).  
 
Figure 6.1: CMOS-based electrochemical detector array for high-throughput quantal analysis. (a) 
Neurotransmitters released from cells diffuse onto an electrode and undergo a redox reaction. The 
oxidation releases electrons into the electrode and results in electrical current at the amplifier, 
which allows a buildup of electrons onto one side of a capacitor, creating a current-dependent 
output, Voxidation. The output of the amplifier is readout periodically and the capacitor is reset using 
a switch to begin the next detection period. (b) The device is bonded onto a PCB to interface the 
CMOS device to external electronics. The final packaging of the device includes a well that permits 
the addition of electrolytic solutions to the top of the electrode array for electrochemical 
experiments. (c) The CMOS-based electrochemical device contains an array of 32 × 32 electrode 
array wherein each electrode is connected to its own dedicated amplifier and a reference electrode 
is integrated on-chip next to the electrode array. To readout the 1024 parallel electrochemical 
detections of secreted neurotransmitters, each column is connected to a dedicated multiplexer. The 
multiplexers stagger the readout time for the amplifiers in its dedicated column, permitting the 
other 31 amplifiers to operate without deadtime. (d) A microphotograph of the 23 µm × 13 µm 
electrodes (white-colored rectangle) patterned throughout the array. (e) The oxide insulation layer 
is etched to provide an opening of approximately 5 µm above the platinum electrodes, providing 
an effective electrode area of 5 µm, which is comparable to the diameter of carbon fibers used for 
traditional single-cell electrophysiology techniques.  
To integrate the new platinum electrodes onto the chip’s surface, a post-CMOS processing 
is performed using a standard photolithography process. The chip is first processed using a 
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negative photoresist, NR9-1500PY, to create a sacrificial layer that defines where metal deposition 
is undesirable. After creating the sacrificial layer, 20 nm of titanium and then 200nm of platinum 
is deposited using sputtering (Kurt J. Lesker Multi-Source RF and DC Sputter System, Kurt J. 
Lesker Company, Jefferson Hills, PA). The sacrificial layer of photoresist is then removed by 
rinsing the chip with acetone. Once all of the photoresist is removed, the platinum electrodes are 
patterned as 23 x 13 µm rectangles as shown in Fig. 6.1d. A 300 nm passivation layer of silicon 
dioxide is then deposited onto the chip using a plasma-enhanced chemical vapor deposition 
machine (STS 310PC, STS Ltd., Wales, UK). To reopen the electrodes for neurotransmitter 
detection the chip undergoes another photolithography process using the negative photoresist 
NR7-1500P, resulting in a protective layer that only permits the etching of the oxide above the 
electrodes. After the protective layer is processed, the device is etched using a reactive ion etcher 
with inductively coupled plasma (Unaxis SLR, Unaxis Materials Inc., Santa Clara, CA). The 
etching process produces circular electrode openings through the oxide passivation layer that are 
approximately 5 µm in diameter as shown in Fig. 6.1e. To remove the remaining NR7 photoresist 
and clean the surface of the array, the device is put into a piranha solution (3:1 mixture of sulfuric 
acid:hydrogen peroxide). The resulting effective area of the electrodes throughout the array are 
comparable to the gold standard CFEs with diameters of ~5 µm [1], [4], [25], [97], [98]. 
After all post-CMOS processing is completed, the chip is packaged to integrate a reservoir 
structure that holds electrolytic solutions on the surface of the array and prevent damage to the 
wire bonds and interfacing electronics. The chip is first bonded to a custom-designed PCB to 
interface with a custom-designed multifunctional data acquisition system. Then, a 3D-printed ABS 
plastic well that is coated in polydimethylsiloxane (PDMS) is bonded to the surface of the electrode 
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array using additional PDMS. The fully packaged device is shown in Fig. 6.1b. After the device is 
packaged, the electrode array is coated with Poly-D-Lysine (PDL) to enhance the adhesion of cells 
to the electrode array during experiments as described in the methods section.  
The amplifiers throughout the array have an average noise level of ~0.42 pARMS when the 
device is operating without electrolytic solution at a 10 kHz sampling rate and a bandwidth of ~4.4 
kHz [24]. In comparison, a recent CMOS device has been developed for high-throughput recording 
of electrochemical current with an array of amplifiers that exhibit a noise level of 1.1 pARMS at a 
sampling rate of ~10 kHz with a bandwidth of ~2 kHz [99]. An electrode that is in contact with 
electrolytic solution suffers from an elevated noise level due to the introduced double-layer 
capacitance. Our previous design had an electrode area of 15 μm × 15 μm, and when electrolytic 
solution was placed onto the array for electrochemical experiments the noise level was 6.16 pARMS 
[24], which is higher than the average amplitude of PC-12 quantal events. The new post-CMOS 
processing presented in this chapter creates an electrode with a diameter of ~5 μm and produces 
an average noise of ~0.9 pARMS under the same conditions. In comparison, a study using a 5 μm 
diameter CFE with the Axopatch 200B amplifier, a high-quality electrophysiology amplifier, had 
a noise level of ~1.4 pARMS with a 10 kHz bandwidth [1]. Our electrochemical sensor array exhibits 
a comparable noise level to a high-quality electrophysiology setup, therefore enabling high-
throughput recordings of quantal events from dopaminergic cells, such as PC-12 cells. 
Based on the noise level of the presented device (~0.9 pARMS) and the typical half-width 
of amperometric spikes recorded from PC-12 cells (~5 ms), we can estimate the smallest quantal 
size that can be detected using this system. Because the integrated noise level for 5-ms events is 
about 0.14 pARMS, the quantal size equivalent noise level for 5-ms signal is ~2000 molecules. 
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6.4 On-chip Recordings at Single-vesicle Resolution.  
Cells are loaded onto the surface of the electrode array as described in the methods section. 
Loaded cells are settled for 5 minutes to the surface of the array, then unattached cells are washed 
away. An example of randomly distributed cells over the electrode array is shown in Fig. 6.2a. The 
cells are present in single-cell form with diameters of 5-10 µm, as well as in clumps (Fig. 6.2b-c), 
throughout the array. Quantal events from the attached cells are recorded in parallel (Fig. 6.3a) 
with the electrodes throughout the array held at a potential of ~800 mV with respect to the reference 
electrode and the amplifiers operating at a 10 kHz sampling rate.  
After a set of recordings are acquired with the device, the recorded exocytotic spikes (Fig. 
6.3b) are analyzed using a quantal analysis program, Quanta Analysis v8.20 [10]. The analyzed 
characteristics of an exocytotic spike include the maximum amplitude of the signal (Imax), the 
duration of the signal at half of its maximum height (t1/2), and the quantal size (Q) as illustrated in 
Fig. 6.3c. After 14 minutes of recording, 477 quantal events are detected from the control group 
(Fig. 6.4). In the control group, the average amplitude of the quantal events is 1.30 pA, the average 
half-width of these events is 7.33 ms, and the average quantal size is 14.3 fC.  
6.5 Rapid Characterization of L-Dopa Therapy on Quantal Release in Minutes.  
L-Dopa is used clinically for PD because it is known to increase the dopamine 
concentration in the central nervous system [2]. To validate the single-vesicle recording capability  
of the presented device, amperometric spikes for both untreated and L-Dopa-treated cells are 




Figure 6.2: On-chip recording of PC-12 cells. (a) The settled cells on the surface of the device. (b) 
Cells are seen in single-cell form, as well as clumps of cells, throughout the electrode array. (c) 
Cells have settled atop the electrode openings, permitting electrochemical monitoring of quantal 
secretion. 
total number of 16 cells and 477 quantal spikes in a 14-minute recording. For the L-Dopa-treated 
cells, a total number of 63 cells and 3534 vesicle secretions are measured, also in a 14-minute 
recording period. L-Dopa-treated cells have a noticeably higher number of quantal events 
compared to the untreated cells and the amplitude of each spike tends to be larger (Fig. 6.4a-b).  
The quantitative analysis on both treated and untreated cell recordings reveals significantly altered 
quantal release characteristics (Fig. 6.4c-f) from these short recordings. Mainly, the amplitude and 
the quantal size are increased with the L-Dopa treatment as anticipated because of L-Dopa’s role 
as a dopamine precursor. The average spike amplitude for treated cells is 1.75 pA, as opposed to 
1.30 pA of untreated cells (Fig. 6.4c). The half-width increased slightly after the L-Dopa treatment 
from 7.33 ms to 9.15 ms (Fig. 6.4d). The L-Dopa treatment increased the average quantal size by 
86%, with the average quantal sizes being 26.6 fC and 14.3 fC for treated and untreated cells, 
respectively (Fig. 6.4e). The number of electroactive molecules contained within each vesicle is 
calculated as described in the methods section. The average number of molecules measured per 
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vesicle release for treated and untreated cells, respectively, are 83,100 and 44,600 molecules (Fig. 
6.4f).  
All recorded quantal events from both cell groups are also compared in histograms (Fig. 
6.4g-j). Secretory cells regulate the vesicles in diameters (ϕ), and we expect to see a well-fitted 
Gaussian distribution of vesicle’s diameter [100]. Quantal size is proportional to the volume of 
vesicles (ϕ3) and plotting of (quantal size)1/3 should produce a Gaussian distribution. As expected, 
the quantal size plots in attomole1/3 show good agreements with Gaussian distributions for both  
treated and untreated cells as seen in Fig. 6.4j. The average quantal size in attomole1/3 for L-Dopa 
treated cells is 0.50 ± 0.11 attomole1/3 (mean ± SD) and is 0.40 ± 0.08 attomole1/3 (mean ± SD) for 
the control group.  
 
Figure 6.3: Parallel neurotransmitter secretion recordings. (a) Representative amperometric 
recordings from a single recording session. (b) A section of a recording showing the fast 
amperometric spikes related to vesicle release events. (c) Each exocytotic event is analyzed for 
key quantal release characteristics (maximum peak of the spike Imax, the half-width duration of 
the spike t1/2, and the quantal size Q). 
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Figure 6.4: Vesicle secretion of neurotransmitter is modulated by L-Dopa treatment. (a) A 
representative recording from the control group. (b) A representative recording after L-Dopa 
treatment that exemplifies an alteration in neurotransmitter secretion characteristics. c-f After L-
Dopa treatment, the quantal release characteristics of the PC-12 cells are significantly altered (n = 
16 for control, n = 63 for L-Dopa, whiskers are drawn from the quartiles to the extreme values, the 
box is generated from the first and third quartile as well as median). (c) The average exocytotic 
spike amplitude increased from 1.3 pA to 1.75 pA after treatment. (d) The average half-width 
increased after treatment from 7.33 ms to 9.15 ms. (e) The average quantal size increased from 
14.3 fC to 26.6 fC after L-Dopa treatment. (f) The change in quantal size correlates to an average 
molecule quantity increase from 44,600 to 83,100 for treated cells. (g-j) Histogram showing 
characteristics from all detected spikes. (two-tailed student t-test: * p < 0.01, ** p < 0.001)  
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6.6 Integration of Microwells for Isolating Single-Cells  
To enable single-cell studies, a layer of SU-8 is integrated on top of each electrode, creating 
wells that are large enough to permit only a single cell from resting atop an electrode as shown in 
Fig. 6.5. The CMOS chip first undergoes the photolithography process to integrate the platinum 
electrode array with the integrated oxide passivation layer that creates 5 µm openings above each 
electrode. Then the protective photoresist used during the etching of the oxide layer is removed 
using resist remover RR4. The chip is cleaned using a piranha solution, Pure Strip, and then 
thoroughly rinsed using deionized water. The chip then undergoes a final photolithography process 
using SU-8 3010 to create the cell-isolating well structures that are nominally 15 µm × 15 µm. 
Microphotographs illustrating the isolation of single-cells to an electrode are shown in Fig. 6.6.  
6.7 Desvenlafaxine and Selegiline 
The new pharmacological substances that are studied in this chapter are desvenlafaxine and 
selegiline. Desvenlafaxine is a pharmacological substance that is used to treat depression and is a 
reuptake inhibitor for the neurotransmitters serotonin and norepinephrine, thus increasing 
extracellular levels of these neurotransmitters in the brain. On the other hand, Selegiline is a 
pharmacological substance that is used for Parkinson’s disease as it is an inhibiter of monoamine 
oxidase (MAO), which oxidizes extracellular monoamines such as dopamine, and will increase 
extracellular levels of dopamine in the brain. To the best of my knowledge, these two  
pharmacological substances have not yet been studied using single-cell amperometry to reveal the 




Figure 6.5: FIB imaging that shows the circular electrode openings inside the SU-8 well openings, 
which promote single-cell studies.  
 
Figure 6.6: High-density neurochemical array for single-cell studies. (a) The 32 × 32 
neurochemical array. (b) 5 µm electrode openings in the SiO2 passivation layer. (c) ~15 µm well 
structures that permit a single-cell to sit atop an electrode. (d) Microphotograph of a single-cell 
resting in a well and cell clumps that fail to fit inside of the well.  
113 
Differentiated cells are used for this pharmacological screening and the analyzed 
characteristics of the recorded exocytotic events are the maximum amplitude of the signal (Imax), 
the duration of the signal at half of its maximum height (t1/2), and the quantal size (Q) of the event. 
From two experimental preparations, neurotransmitter secretion was captured from 26 cells in the 
control group. This control group exhibits an Imax of 1.11 pA, a half-width of 46.0 ms, and a quantal 
size of 0.103 pC. Then secretion was captured from 29 cells (1 experimental preparation) in the 
serotonin treated group and 17 cells (1 experimental preparation) in the norepinephrine treated 
group. The serotonin treated group of cells show little difference compared to the control group 
and exhibits a lower Imax of 1.06 pA, a shorter half-width of 45.7 ms, and a smaller quantal size of 
0.097 pC. However, the norepinephrine treated group exhibit a larger Imax of 1.74 pA, a shorter 
half-width of 20.6 ms, and a smaller quantal size of 0.061 pC, all of which are statistically 
significant (p < 0.05) compared to the control. For the new pharmacological treatment 
experiments, secretion was captured from 22 cells (1 experimental preparation) in the 
desvenlafaxine treated group and 55 cells (1 experimental preparation) in the selegiline treated 
group. The desvenlafaxine treated cells exhibit a larger Imax of 1.16 pA, a longer half-width of 64.6 
ms, and a larger quantal size of 0.124 pC, of which only the half-width is different from the control 
with statistical significance (p < 0.05). For the selegiline treated cells, this group exhibits a larger 
Imax of 1.17 pA, a shorter half-width of 38.7 ms, and a smaller quantal size of 0.064 pC, all of 
which are similar to the control group. Plots summarizing the captured secretion characteristics 
are shown in Fig. 6.7.  
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Figure 6.7: Pharmacological modulation of neurotransmitter secretion. Modulations include 
incubation with extracellular neurotransmitters, serotonin and norepinephrine, and treatment with 
pharmacological substances desvenlafaxine, an uptake inhibitor, and selegiline, a monoamine 
oxidase inhibitor. (a) The average amplitudes are 1.11 pA, 1.06 pA, 1.74 pA, 1.16 pA, and 1.17 
pA for the control, serotonin, norepinephrine, desvenlafaxine, and selegiline experiments 
respectively. (b) The average half-widths are 46.0 ms, 45.7 ms, 20.6ms, 64.6 ms, and 38.7 ms for 
the control, serotonin, norepinephrine, desvenlafaxine, and selegiline experiments respectively. (c) 
The average quantal sizes are 0.103 pC, 0.097 pC, 0.061 pC, 0.124 pC, and 0.084 pC for the 
control, serotonin, norepinephrine, desvenlafaxine, and selegiline experiments respectively. [The 
boxes are generated from the first and third quartile as well as median and the whiskers are drawn 
from the quartiles to the extreme values.] (two-tailed student t-test: * p < 0.05) 
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6.8 Discussion 
Using the presented CMOS integrated electrochemical sensors, we are able to perform 
hundreds of amperometric recordings in minutes as opposed to weeks using the conventional CFE 
approach [26]. Significant cost reduction in instrumentation for quantal release analysis will allow 
the rapid evaluation of existing and emerging treatments for their molecular effects on exocytosis.  
Using the integrated silicon device, we were able to characterize the effects of L-Dopa 
treatment at the single vesicle level, and our results agreed with previous studies [2], [97], [101]–
[104]. After treating PC-12 cells with L-Dopa we observed a 35% increase in Imax which is similar 
to the previous reports [101], [103]. Modulation of t1/2 as a result of L-Dopa treatment has increased 
the duration of quantal events by 47% in MN9D cells [5] and by 10% [101], 38% [103], and as 
large as 88% [104] in PC-12 cells. Our results showed a similar increase in t1/2 of 25% after L-
Dopa treatment. Across all studies, L-Dopa treatment increases the quantal size within each 
vesicle; treated bovine chromaffin cells exhibited a 70% increase [105]; MN9D cells exhibited an 
increase of 40% [5]; PC-12 cells exhibited an increase of 20% [101], 26% [104], and 63% [103]; 
and our measurement showed an 86% increase in quantal size. 
For the differentiated cells exposed to serotonin, the modulation in these parameters is 
minimal. Because PC-12 do not express serotonin, there may not be an efficient uptake mechanism 
compared to the naturally expressed dopamine or norepinephrine. The cells exposed to 
norepinephrine show an increase in Imax (56%) and a decrease in the half-width (55%) and quantal 
size (41%) with statistical significance (p<0.05) (Fig. 6.7). For the new pharmacological studies 
(Fig. 6.7), desvenlafaxine exhibits a longer half-width, 40% longer compared to the control, that 
is statistically significant (p < 0.05). However, the selegiline treatment does not exhibit statistically 
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significant modulation of secretion characteristics. This reveals that the selegiline exposure and 
dosage detailed in the methods section may not modulate secretion characteristics and higher 
dosage and longer exposure may reveal some unknown effects at the single-cell level. 
6.9 Methods 
6.9.1 Recording and Stimulation Solutions 
The recording bath solution consists of 150 mM of NaCl, 5mM of KCl, 2 mM of CaCl2, 
1.2 mM of MgCl2, 10 mM of HEPES, and 11 mM of Glucose. Additional glucose was added to 
adjust the osmolality of the recording solution to 320 mmol/kg and the pH was adjusted to 7.3 
using NaOH. The high K+ stimulation solution consists of 55 mM of NaCl, 100mM of KCl, 5 mM 
of CaCl2, 2 mM of MgCl2, 10 mM of HEPES, and 10 mM of Glucose. The stimulation solution’s 
osmolality was adjusted to 320 mmol/kg by adding glucose to match the osmolality of the 
recording bath solution and the pH was adjusted to 7.3 using NaOH. Both solutions were prepared 
using water from a purification system and then further filtered after preparation to ensure their 
sterility.  
6.9.2 PC-12 Cell Culture 
The PC-12 cells were obtained from the American Type Culture Collection (ATCC) 
(Manassas, VA) and were cultured using T-75 flasks in an incubator at 37ºC with 5% CO2. The 
culture media consists of RPMI-1640 (Gibco) media that was supplemented with 10% heat-
inactivated horse serum (Gibco), 5% fetal bovine serum (ATCC), and 1% penicillin-streptomycin 
(Gibco). The media was changed every 2-3 days and the cells were subcultured when the cell 
density was approximately 4 × 106 cells/mL. The cells used for the control group and the L-Dopa 
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treated group are first split from one flask into two separate flasks the day of, or before the on-chip 
measurement.  
For the experiments using differentiated cells, cells are treated with 5 µM of 
dexamethasone, a differentiation path that has been found to enhance the excitability of PC-12 
cells when stimulated [107]. These differentiated cells are treated and loaded onto the 
neurochemical microelectrode array for monitoring neurotransmitter secretion on days 5-8 after 
differentiation is initiated. 
6.9.3 Experimental Procedure 
Cells were first detached from their flasks by a washing process using culture media and 
the cell concentration was adjusted to approximately 2 × 106 cells. The detached cells were first 
spun down to a pellet in a centrifuge at 200g for 5 minutes. The supernatant was discarded, 5 mL 
of the recording solution was added, and the cells are resuspended using a 20 mL syringe with a 
22-gauge needle. The cells were once again spun down to a pellet at 200g for 5 minutes, the 
supernatant was discarded, and 1 mL of new recording solution was added. The approximate 2 × 
106 cells were resuspended once more and then 20 µL of this cell solution was loaded directly onto 
the electrode array. Once loaded onto the device, the cells were given 5 minutes to settle to the 
surface of the array. During this settling period, a prepared Ag|AgCl wire reference electrode was 
placed into the well. Any unattached cells were removed from the device by washing the array 
with more recording solution using a perfusion system. To treat the electrode array with PDL 
(Gibco), the device was incubated with 0.1-mg/mL PDL solution on top of the array for 1 hour. 
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The device was then rinsed thoroughly using deionized water and dried for at least 1 hour before 
the array’s first electrochemical experiment. 
A brief recording of the quantal release from non-stimulated cells resting on the electrode 
array was performed before the high K+ stimulation solution was added to the electrode array. The 
stimulation solution was then added using a perfusion system, which was operated for about 1 
minute to saturate the cells with the exocytosis-inducing stimulant. The recording lasted for 14 
minutes after the first stimulation. After the cells have rested for at least 5 minutes following the 
first stimulation, the perfusion system was used again to add more of the high K+ stimulant to re-
stimulate the cells halfway through the recording period. When performing experiments with L-
Dopa treated cells, the cells are exposed to 100 µM of L-Dopa for 1 hour prior to executing the 
cell loading process. To determine the viability of the cells during the recordings of 
neurotransmitter secretion, trypan blue was added to the electrode array after all recordings are 
complete. The solution on the array was first exchanged with fresh recording bath solution and 
then drained until 1 mL of solution remains. Then, 1 mL of trypan blue was added to the well to 
stain any dead cells atop the array. After 5 minutes of cell staining, the trypan blue was removed 
by perfusion and exchanged with new recording solution and the array was inspected using a 
microscope.  
For experiments using differentiated cells, the cells are first removed from the flask and 
then spun down to a pellet in a centrifuge at 200g for 5 minutes. Then the media is removed and 
the cells are treated with 2 ml of Trypsin (0.25% EDTA) for 2 minutes and are lightly aspirated 
using a pipette. Then 8 mL of culture media is used to neutralize the Trypsin and the cells are spun 
down to a pellet in a centrifuge at 200g for 5 minutes. The supernatant is then removed, 5 mL of 
119 
fresh media is added, and the cells are resuspended using a 20 mL syringe with a 22-gauge needle. 
Then 20 mL of fresh media is added and cells are removed for counting. After counting, 
approximately 2 × 106 cells are removed and spun down to a pellet in a centrifuge at 200g for 5 
minutes. The supernatant is removed and1 mL of calcium and magnesium-free phosphate-buffered 
saline is added to inhibit cell clumping during the loading procedure. The cells are resuspended 
using a 20 mL syringe with a 22-gauge needle. Then the 20 µL of cells are loaded onto the array 
and given 10 minutes to settle into the SU-8 wells (Fig. 6.6d).  
For these experiments, the differentiated cells undergo the following treatments. To study 
the reuptake inhibition effects of desvenlafaxine, an experimental group of cells are treated with 
10 µM of serotonin for 30 min. Then for the desvenlafaxine group of cells, they are first treated 
with 5 µM of desvenlafaxine for 30 min and then 10 µM of serotonin is introduced to the cells for 
30 min. Another uptake experiment is performed using the PC-12 cells to address concerns about 
the efficiency of serotonin uptake from these cells as they do not naturally express serotonin in 
their vesicles, but they do express norepinephrine and dopamine. The second uptake experiment 
exposes the cells to 100 µM of norepinephrine for 60 min. The selegiline group of cells are treated 
with 5 µM of selegiline for 30 min.  
6.9.4 Statistical Analysis 
All of the cell recordings are analyzed in Igor Pro 8 using Quanta Analysis version v8.20 
[10]. All recordings are filtered with a 1 Hz high pass filter, to remove low-frequency fluctuations 
resulted from perfusion steps, and a low pass binomial smoothing set to 100 Hz. Signals are 
detected as quantal events when the signal’s first-order time derivate is 5 times greater than the 
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standard deviation of the background noise. All individual exocytotic spikes are analyzed for their 
quantal size, amplitude, half-width, and number of molecules. The quantal size was calculated 
based on the integration of the electrochemical current induced during an exocytotic spike in pico-
coulomb (pC). The amplitude is determined from the baseline to the peak of each spike in pico-
ampere (pA). The number of molecules released per vesicle can be calculated by dividing the 
quantal size by 2q (q is the electron charge). Exocytotic events from individual cells are 
heterogeneous and overrepresentation is possible from cells that are highly active [102]. In order 
to prevent the overrepresentation of highly-active cells, the median value of all the spikes from a 
single cell is used as n (each sample) in the statistical analysis, rather than using individual spikes 
as n. This method is consistent with other amperometric studies[24], [34], [108], [109].  
6.10 Conclusion 
Using the presented CMOS integrated electrochemical sensors, we are able to acquire 
numerous amperometric recordings in an experiment, providing rapid results compared to the 
conventional amperometry technique that can take from weeks to months to amass a comparable 
dataset [26]. Using the integrated silicon device, we were able to characterize the effects of L-
Dopa treatment at the single vesicle level and we were able to study the secretion modulation by 
serotonin uptake, norepinephrine uptake, desvenlafaxine treatment, and selegiline treatment at the 
single-cell level. This chapter illustrates the high-throughput screening capabilities of the system 
developed in this dissertation. Using this novel technology, we can significantly accelerate the 
study of neurodegenerative disorders, such as Parkinson’s disease and Alzheimer’s disease, as well 
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as new pharmacological treatments that affect neurotransmitters in the brain at the single-cell level, 





CHAPTER 7:  NEUROTRANSMITTER-MEDIATED BIOHYBRID SYNAPSE 
7.1 Chapter Notes 
Bio-inspired computing revolutionizes machine learning and artificial intelligence by 
mimicking the efficient biological systems. Artificial neural networks (ANNs) are inspired by the 
brain, in which the synaptic connectivity between neurons achieves complex classification and 
data processing tasks. Although ANNs closely emulate the biological neural network (BNN), the 
BNN relies heavily on neurochemical synaptic transmission which contributes to the stochastic 
computing of the brain. In biological synapses, membrane-bound neurotransmitters are released in 
quantal events to the extracellular space at the synaptic clefts. In this chapter, a new biohybrid 
synapse that produces quantal neurotransmitter secretion to relay information to the artificial 
postsynaptic receptor is discussed. The neurochemical biohybrid synapse paves the way for a new 
generation of brain-inspired computing by enabling single biological cell to single artificial neuron 
connectivity. We also demonstrate the dynamic synaptic weighting in the biohybrid synapse which 
affects synaptic activities. The work described in this chapter was completed with Mingjie Lin and 
Brian N. Kim. 
7.2 Introduction 
The brain excels in sophisticated learning and control tasks compared to the modern 
computing machinery, despite using significantly less computation resources. Neurons receive 
inputs from thousands of excitatory synapses which enables them to recognize multiple 
independent patterns despite the presence of noise and pattern variation. Recent advances in bio-
inspired computing mimic certain aspects of biological neural networks, such as parallel 
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distributed information processing, spike-time encoding, synaptic plasticity, and homeostasis. 
However, artificial intelligence needs new hardware, not just new algorithms, to advance the 
dimensionality of synaptic connectivity. The scalability of silicon circuits is limited as we reach 
the end of Moore’s law and there is no clear solution to form thousands of synaptic connections 
from each processing unit. The vision of our work here is to take advantage of biological intricacy 
and sophistication as parts of the computing solution, rather than to view them as complex 
problems. As such, biological tissues, such as the cortex neural layer, are no longer seen as 
unfathomable living materials, but rather as potential computational resources. 
Artificial neural networks (ANNs) are inspired by the brain, wherein the synaptic 
connectivity between neurons achieves complex classification and data processing tasks. Although 
ANNs closely emulate the biological neural network (BNN), one important distinction between 
the two is that the BNN relies heavily on neurochemical synaptic transmission which contributes 
to the stochastic computing of the brain. In biological synapses, intracellular neurotransmitters are 
bound in vesicles (quanta) which are then released in quantal events to the extracellular space 
through exocytosis at the synaptic clefts (Fig. 7.1a). Although the exocytotic events are moderately 
coordinated with neuronal excitation, the number of vesicles that participates in neurotransmitter 
secretions, and the timing of exocytosis, appear to be random in nature. Also, some portion of 
neurotransmitter secretions is non-regulated and can occur without any excitation. These 
characteristics are referred to as synaptic noise and are attributed to the imprecise operation of the 
human brain [110], [111]. Nonetheless, the stochasticity is one of the defining qualities of the 
human brain that enables energy- and resource-efficient computing.  
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Previous work has demonstrated the biohybrid concept to merge biological tissue into 
electronic devices [112]. Neuroendocrine cells are interfaced with a PEDOT:PSS transistor, which 
serves as the post-synaptic cleft. The published work has demonstrated short-term and long-term 
modulation of a biohybrid synaptic channel by voltage pulse induced ion flow into the synaptic 
channel and irreversible modulation of the synaptic channel due to oxidation of neurotransmitters, 
such as dopamine, respectively. However, this biohybrid synapse does not approach emulation of 
neural synapses as a single postsynaptic connection interfaces with multiple presynaptic cells. 
Also, it does not capture the individual vesicular secretion events, which is a key characteristic of 
synaptic transmission in a biological synaptic cleft.  
In this chapter, we introduce a new biohybrid synapse that communicates through vesicular 
secretion, which mirrors the neuronal synaptic communications, to relay information to the 
artificial postsynaptic receptor (Fig. 7.1b). The biohybrid synapses pave the way for a new 
generation of brain-inspired computing by enabling single biological cell to single artificial neuron 
connectivity. The proposed biohybrid technology can achieve two purposes: (1) serving as a part 
of artificial intelligence interconnecting a biological layer to an artificial layer (Fig. 7.1c), (2) being 
an independent reservoir computing device that can utilize the complex biological synaptic 
connectivity (Fig. 7.1d) (1000s of synaptic connections per neuron, compared to 10s in an artificial 
neural network), which is crucial in the efficient computing of the human brain. 
7.3 Neurochemical Biohybrid Synapse 
Each biohybrid synapse integrates a neuroendocrine single cell (PC-12) and a neurochemical 
microelectrode. The neuroendocrine cells natively release dopamine molecules in quantal events 
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which is identical to dopaminergic neurons [113]. The integration of single cells enables the 
biohybrid synapse to connect one biological cell to an individual artificial neuron. Thusly, the 
neurochemical sensor must be able to detect and quantify the fast neurotransmitter release events 
which are occurring at the single-vesicle level.  
 
Figure 7.1: Neurotransmitter-mediated biohybrid synapse using single-cell neurochemical sensor. 
(a) In the synaptic cleft, neurotransmitters are released in quantum (vesicle). (b) The new biohybrid 
synapse integrates a presynaptic secretory cell which can secrete neurotransmitters in quantal 
events. Each biohybrid synapse measures neurochemical secretions at a quantum resolution which 
can then be used to interact with the artificial neural network. (c) Using biohybrid synapses, 
biological tissue can be integrated as a part of a neural network which can achieve computing 
tasks. (d) Also, reservoir computing using a biological neural network can be achieved using 
biohybrid synapses as the interface. 
7.3.1 Design of Biohybrid Synapse 
To achieve this, we have previously designed a neurochemical microelectrode array 
(MEA) using complementary metal-oxide-semiconductor (CMOS) technology which is capable 
of resolving neurotransmitter secretion events with single-vesicle resolution [24], [34], [51], [61], 
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[114], [115]. To the best of our knowledge, our neurochemical CMOS-MEA has the lowest noise 
level (~0.4 pARMS at 10 kS/s) for a large MEA [114]. The CMOS-MEA integrates 1024 
neurochemical sensors into a single device which can be used to establish high-throughput 
connectivity between BNNs and ANNs. The CMOS device is first fabricated using a standard 0.35 
µm CMOS process. The CMOS chip contains 1024 integrated transimpedance amplifiers in a 32 
× 32 array. The integrated transimpedance amplifiers are based on an integrating capacitor design 
in which the electrode node is regulated by the negative feedback of an operational amplifier. The 
oxidation current caused by the electroactive neurotransmitter molecules is integrated in the 
capacitor which results in a current-dependent voltage output. This output voltage is readout by a 
time-division multiplexer which reads from 32 amplifiers in a column. Each column of 32 
amplifiers has its own dedicated multiplexer. The on-chip MEA is integrated directly on the CMOS 
chip by post-CMOS processing. The post-CMOS processing is performed using a standard 
photolithography process. First, the platinum layer is patterned using a lift-off process. Then, a 
thin silicon dioxide (300 nm) layer is deposited and etched to pattern an electrode passivation 
layer. Small openings to the platinum layer formed by the silicon dioxide layer define the effective 
microelectrode size (5 µm in diameter). After the integration of the on-chip MEA, a 20-µm layer 
of SU-8 is patterned above the neurochemical CMOS-MEA. The SU-8 layer serves as a single-
cell isolator, which filters cells by size and only permits single cells to make contact with the 
neurochemical sensors to form the hybrid synapse. Clumps of cells will be rejected by the SU-8 
because they will be too large to fit through the SU-8-defined openings (Fig. 7.2).  
The electrode passivation layer enables the detection of neurotransmitter secretion with 
single-vesicle resolution by reducing the effective area of the electrode. The reduced electrode area  
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Figure 7.2: High-density single-cell neurochemical sensor array. (a) The neurochemical sensor 
integrates on-chip electrodes. The electrode opening is defined by a layer of SiO2. Subsequently, 
a layer of SU-8 is patterned on the neurochemical sensor to produce single-cell biohybrid synapses. 
(b-c) The SiO2 opening is 5 µm in diameter. The SU-8 opening is 12 µm in diameter. The single-
cell diameter of PC-12 cells is ~7 – 10 µm and therefore the cells will fit into the SU-8 opening.  
confines the area of the electrode-electrolyte interface, which directly affects the double-layer 
capacitance at this interface. This double-layer capacitance significantly affects the noise response 
of the transimpedance amplifier. Without the electrode passivation, the 15 μm electrode area has 
exhibited an average noise level of ~6.16 pARMS (Fig. 7.3) [24]. When introducing the passivation 
layer that defines an active area of 5 μm, the electrodes exhibit an average noise level of ~0.9 
pARMS (Fig. 7.3) [114]. This significant noise improvement enables the detection of single-vesicle 
neurotransmitter secretion from PC-12 cells which have small quantal content. 
7.3.2 Neurotransmitter-mediated Synaptic Transmission 
Using the single-cell neurochemical sensor, we demonstrate the neurotransmitter-mediated 
biohybrid synapse (Fig. 7.4). For in-vitro models of presynaptic neuron cells, neuroendocrine PC-
12 cells are used. The cells are cultured at 37˚C in RPMI-1640 media supplemented with 10% 
horse serum, 5% fetal bovine serum, and 1% penicillin-streptomycin. Additionally, the cells are  
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Figure 7.3: Noise spectral density of a 15 µm microelectrode and 5 µm microelectrode. The large 
electrode experiences a large double-layer capacitance from the electrode-electrolyte interface. 
The large input capacitance attached to the transimpedance amplifier contributes to the high-
frequency noise, which is significant in the 15 µm microelectrode. The small 5 µm microelectrode 
does not exhibit any high-frequency noise from the input capacitance within the measurable 
bandwidth.  
differentiated with 5 μM of dexamethasone, which enhances the excitability of the cells to 
stimulation [107]. On days 5-8 after differentiation is initiated, the PC-12 cells are loaded onto the 
chip and single PC-12 cells are contained atop a neurochemical microelectrode (Fig. 7.4a). The 
PC-12 cells spontaneously release dopamine molecules without any stimulation. Each quantal 
release is measured by a spike, which corresponds to a single-vesicle neurotransmitter release from 
the cell membrane (Fig. 7.4b).  
The observed neurochemical secretions are stochastic, and the size of each quantal 
secretion is also random. The amplitude of spikes varies from 0.5 – 15 pA with an average of 4.47 
pA. The average half-width (duration) is 38.3 ms, ranging from 8 – 122 ms. Using the integration 
of the oxidation current measured from each spike, we can estimate the quantal size of each vesicle. 




Figure 7.4: Single-cell biohybrid synapse. (a) Microphotography of a single PC-12 cell loaded into 
the SU-8 well. (b) The exocytotic events within the biohybrid synapse are mediated by the same 
vesicle fusion process, which mediates the neurotransmitter signal transmission within a biological 
synaptic cleft. Each spike monitored corresponds to a single vesicle secretion event.  
per vesicle. Based on this experiment, this biohybrid synapse closely mimics the mechanism of 
synaptic transmissions which are neurotransmitter mediated. 
7.4 Synaptic Plasticity in Biohybrid Synapse 
For the biohybrid synapses to be applicable to be a part of computation machinery, it is 
crucial to demonstrate synaptic plasticity. In biological cells, multiple approaches can be adapted 
to show synaptic plasticity, either short-term or long-term. For example, neurons can commonly 
be triggered to increase synaptic activities by inducing calcium influx. This effect is short-term 
and, therefore, neurons can recover to the pre-stimulated condition in a few minutes. 
Pharmacological modulations can have long-term effect in synaptic transmission which affects 
underlying mechanisms of vesicle trafficking and exocytosis. For example, L-Dopa, a Parkinson’s 
disease treatment, can increase the number of neurotransmitters in each vesicle, and therefore, 
increase the quantal size as well as the amplitude of each spike [2].  
In this section, we demonstrate the dynamic short-term synaptic plasticity by triggering 
calcium influx (Fig. 7.5a-b). At the start of the neurochemical recording, the biohybrid synapse  
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Figure 7.5: Dynamic synaptic plasticity in biohybrid synapses. (a) In the synaptic cleft, vesicles 
undergo spontaneous release which causes neurotransmitter secretion. (b) Upon calcium influx, a 
greater population of vesicles undergoes exocytosis which results in a significant extracellular 
neurotransmitter concentration. (c) In the biohybrid synapses, the calcium influx can be used to 
modulate the synaptic weight, causing a temporary increase of exocytotic activities. This 
experiment shows the short-term plasticity of biohybrid synapses. 
exhibits the spontaneous release of neurotransmitters (Fig. 7.5c). At around 380 seconds, a calcium 
influx is induced by introducing a high concentration of potassium (70 – 140 mM) in the 
extracellular space for ~60 seconds. By triggering calcium influx, vesicle populations primed at 
the membrane undergo exocytosis to release their neurochemical content. After the modulation, 
the synaptic activity is increased with frequent single-vesicle secretion events compared to the pre-
modulation condition. The increased synaptic activity is temporary as it is expected to return to 
the spontaneous level in a few minutes.  
7.5 Conclusion 
This biohybrid approach has several unique advantages over ANNs: (1) the integration of living 
neural tissues with natural computing power into functional computing machinery, (2) the 
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neurochemical synaptic transmission closely mimics neuronal synaptic connectivity, (3) the 
synaptic plasticity is non-deterministic which enables the stochastic computing of the human 
intelligence in in vitro electronic devices. By implementing biohybrid synapses into computing 
machinery, we will be able to generate stochastic computing architectures which are highly fault-
tolerant and resilient, because any local perturbations of computing accuracy can dissipate globally 
and remain inconsequential to the output [116], [117].  
In an effort to interface with a large neural network, the presented work provides a highly 
scalable technology. Because the biohybrid synapse is designed in a CMOS chip, tens of thousands 
of identical biohybrid synapses can be fabricated in a small surface (~a few mm2) in order to 
interface with a complex BNN.  
7.6 Discussion 
Our future goal is to use this biohybrid synapse technology to stitch the biological fabric 
(BNN) and the artificial fabric (ANN) into a single computing machinery, enabling a new 
paradigm of biocomputing. To achieve this, we are investigating scalable methods to establish 
input to interface with the biohybrid synapse. One approach is to add the input layer to these 




CHAPTER 8:  CONCLUSION AND FUTURE DIRECTION 
The presented monolithic CMOS-based neurotransmitter detection system can capture a 
large pool of quantal events in the span of minutes, providing rapid results compared to the 
conventional amperometry technique that can take from weeks to months to amass a comparable 
dataset [26]. Using this novel technology, we can significantly accelerate the study of 
neurodegenerative disorders, such as Parkinson’s disease and Alzheimer’s disease, as well as new 
pharmacological treatments that affect neurotransmitters in the brain at the single-cell level, such 
as drugs for depression or Parkinson’s disease. One of the future goals of this system is to reveal 
the unknown modulation of neurotransmitter secretion at the single-cell level by a pharmacological 
substance. By understanding the effects that pharmacological substances have at the single-cell 
level, drugs may become applicable for new therapeutic cases. Another future goal is to use this 
biohybrid synapse technology to stitch the biological fabric (BNN) and the artificial fabric (ANN) 
into a single computing machinery, enabling a new paradigm of biocomputing.  
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